pe pagina
  • 107.00 lei

    The physician and botanist William Woodville (1752–1805), a proponent of inoculation against smallpox, was in 1791 appointed physician to the London Smallpox and Inoculation Hospital. Five years later, Edward Jenner announced his experiments with vaccination - inoculation with the much milder cowpox, which conveyed immunity to smallpox without the attendant risk of catching the often fatal disease. Woodville eagerly pursued trials using vaccination, and published the results in this 1799 work, which describes two hundred cases where patients (usually children) were vaccinated with matter obtained from either cows or other cowpox sufferers, and supplies a table of the patterns of infection from person to person. Most of these patients were later tested by inoculation with smallpox, and none caught the disease. This demonstration of the safety and efficacy of vaccination led to its much wider adoption, to which Woodville gave practical support in both England and France.

  • Ebola: An Evolving Story
    La comanda in aproximativ 4 saptamani
    12000lei 108.00 lei

    The book is a narrative of the unfolding of the Ebola virus disease outbreak from a scientific view point. The author provides an analysis of the scientific basis of public health policies that have influenced the public's, and the medical community's, abilities to understand the virus and the disease. This is done in the context of providing insights into the biology of the virus, and exploring open questions, including its likely modes of transmission. The author has included citations from the scientific literature and the press, as well as quotes from expert interviews. The book will help sort out the fact from fiction, given the confusion that arose after the virus arrived in the US. The author used his objective research skills and knowledge of evolutionary genetics and molecular biology to find out what was known, and what questions remained unanswered, and even what questions remained unasked.Written in an accessible style, it is intended for the educated general public, scientists, policy makers, health care workers, and politicians. It delves into the problems of trying to derive a logic-based understanding of a highly lethal emerging disease in 2014, when research funding cuts have gutted research institutions, and when public health institutions really were woefully unprepared. It is a highly distinct narrative analysis that is sure to stimulate new research and thinking in public policy. It will inform thousands of people of the nature of the virus, how it works, in terms they are likely to be able to understand. It will allow others to rapidly catch up with the story of Ebola.

  • 134.00 lei

    First published in 1903, this book presents a wide-ranging study of rabies. Three key areas of the disease are explored: its causation in the individual organism, its place among germ diseases with the end of bacterial agency in the animal economy, and its origin in the animal kingdom. This book will be of value to anyone with an interest in epidemiology and the historical understanding of rabies.

  • Cerebro-Spinal Fever
    La comanda in aproximativ 4 saptamani
    140.00 lei

    In 1915, an outbreak of meningitis affected the Eastern Command in the British Army. Foster and Gaskell, both Captains in the Royal Army Medical Corps in the Territorial Army, were on hand to witness the effect of the disease, and the following year they published this study of the disease's symptoms and treatment as they observed it. The text is accompanied by plates illustrating meningitis' effects on the skin and brain. This book will be of value to anyone with an interest in the history of epidemiology and the treatment of meningitis.

  • 146.00 lei

    Originally published in 1915, this book gathers together a collection of papers on tuberculosis by the renowned British epidemiologist Arthur Ransome (1834–1922). The papers approach the subject from a number of different viewpoints, encompassing both scientific and public health perspectives, and draw on Ransome's experience of more than fifty years fighting tuberculosis. Illustrative figures and notes are also incorporated within the text. This book will be of value to anyone with an interest in tuberculosis and the history of medicine.

  • 156.00 lei

    Nelson's Neonatal Antimicrobial Therapy is your go-to reference for treating neonates with infectious diseases. This handy reference provides evidence-based recommendations from leading experts in antimicrobial therapy for the treatment of infectious diseases in neonates. Get expert advice on: Dosing for neonates, including low-birth-weight newborns Drug selection for bacterial, fungal, viral and parasitic pathogens Drug Stewardship And more

  • 160.00 lei

    Covers four of the major strands of the courses taught to medical undergraduates under the umbrella terms of epidemiology and public health.

  • 170.00 lei

    Originally published in 1917, as part of the Cambridge Public Health Series, this book was written to provide a guide for those 'interested in the stamping out of tuberculosis'. The text approaches the disease from an outlook based around experimental pathology, avoiding the clinical perspective already well represented in previous works by other researchers. Numerous illustrative figures and an appendices section are also included. This book will be of value to anyone with an interest in public health, the history of medicine and the historical understanding of tuberculosis.

  • 18300lei 174.00 lei

    Provides a detailed, evidence-based overview of a range of topics necessary for understanding infectious diseases. It is primarily aimed to offer important background on regional disease epidemiology, pathogenesis, social, and ethical aspects of disease control through the use of specific antimicrobial agents and preventive vaccines. Different aspects of infectious disease are addressed and each chapter begins with an annotation of key terms, and definitions and finishes with a concrete summary, using bullet points. The excellent tables and illustrative figures in each chapter are presented with useful proactive diagnostic essentials including nonculture-based molecular advances for early diagnosis and appropriate management. Thirty different chapters are dealt from subject matters on antibiotic uses, vaccine prevention strategies for all ages, and disease transmission control in hospital care environments. The second edition provides wealth of timely information and up-to-date overview of the commonly encountering infectious diseases in the clinical practice. Includes material on the most important newly emerging and re-emerging diseases. Each chapter is amply illustrated with photographs and figures provide unparalleled visual guidance. Contains reference tables with differential diagnoses, laboratory diagnoses and treatment aspects. Valuable appendices provide cross reference information for each of the bacterial, viral, fungal, and parasitic diseases.

  • 189.00 lei

    In this second volume of his history of epidemics in Britain, controversial physician Charles Creighton continues his examination of diseases in Britain from the time of Charles II to the time of the volume's publication in 1894. The work is broken down by disease, ranging from typhus to childhood diseases, as well as examining the origin and consequences of specific outbreaks in the United Kingdom, Ireland and among British troops abroad. This work will be of value to medical historians and those with an interest in epidemiology.

  • 21200lei 190.00 lei

    An essential resource for practitioners in infectious diseases and microbiology, studying for the new FRCPath Part 1 infection examination accredited by the Royal College of Pathologists, and trainees sitting the membership exams of the Royal College of Physicians.

    Including over 300 multiple choice questions in an exam-style Q&A format, this guide provides an invaluable revision platform for domestic and international trainees alike, with scope to present infection-based support for other medical specialties, where infection forms a core component, including intensive care.

    Authored by leading specialists in infectious diseases and microbiology, this invaluable training guide is the first of its kind to cover both undergraduate and postgraduate material in infectious diseases. Mapping directly from the FRCPath and RCP infection curricula, students are able to explore areas of curriculum to gain knowledge and optimise decision-making skills, under pressure.

      Half-title

      Title page

      Copyright information

      Contents

      Preface

      Reference Ranges

      Haematology

      Clotting

      Biochemistry

      Blood Gases

      CSF

      Abbreviations

      Chapter 1 Biology of Bacteria, Viruses, Fungi and Parasites and the Host–Pathogen Interactions

      Questions

      Answers

      Chapter 2 Microbiology and Virology Laboratory Practice

      Questions

      Answers

      Chapter 3 Health and Safety for Infectious Diseases, Microbiology and Virology

      Questions

      Answers

      Chapter 4 Principles of Public Health in Relation to Infectious Diseases, Microbiology and Virology

      Questions

      Answers

      Chapter 5 Infection Prevention and Control

      Questions

      Answers

      Chapter 6 Important Clinical Syndromes Presenting from the Community and within Healthcare Organisat

      Questions

      Plates

      Answers

      Chapter 7 Understanding the Use of Antimicrobial Agents

      Questions

      Answers

      Chapter 8 Vaccination

      Questions

      Answers

      Chapter 9 The Management of HIV Infection, Opportunistic Infections and Complications of Other Cause

      Questions

      Answers

      Chapter 10 Travel and Geographical Health; Imported Infection and the Provision of Pre-travel Health

      Questions

      Answers

      Index

  • 194.00 lei

    In this first volume of his history of epidemics in Britain, controversial physician Charles Creighton begins his examination of diseases in Britain from the first British epidemic in 664 AD to the end of the Great Plague in 1666. The work is broken down by time period and disease, ranging from Bede's record of the plague of 664–684 to 'the French pox', as well as outbreaks during sea voyages and in the early colonies. This work will be of value to medical historians and those with an interest in epidemiology.

  • 207.00 lei

     

    • Concise pocketbook designed to support physicians, virologists, and immunologists in their day-to-day practice
    • Written and edited by key thought leaders and developed using the latest clinical evidence and guidelines
    • High quality full-color supportive illustrations, tables and graphs enable complicated concepts to be made clear to readers with different levels of background understanding

    About this book

    This concise pocketbook will provide readers with an overview and background of meningococcal disease, treatment options and emerging therapies, and methods of prevention. The book was originally commissioned due to recent developments in vaccinations to prevent meningococcal disease.

    This book reviews the disease progression and associated risk factors; its pathogenesis and diagnosis; methods of treatment and prevention, both current and emerging; and the future directions of meningococcal disease management. The book is ideal for busy healthcare professionals, as it covers all aspects of the disease and its treatment in a condensed and manageable format, whilst including the most up-to-date treatment guidelines and algorithms.

     

    Table of contents (7 chapters)

     

    ·         Introduction and epidemiology of meningococcal disease

    Trotter, Caroline (et al.)

    Pages 1-14

    ·         Carriage and transmission of

    Trotter, Caroline L. (et al.)

    Pages 15-23

    ·         Pathogenesis of invasive disease

    Øvstebo, Reidun (et al.)

    Pages 25-43

    ·         Diagnosis of meningococcal disease

    Tsang, Raymond (et al.)

    Pages 45-55

    ·         Clinical aspects of meningococcal disease

    Pelton, Stephen (et al.)

    Pages 57-73

    ·         Treatment of meningococcal disease

    Nadel, Simon (et al.)

    Pages 75-90

    ·         Prevention of meningococcal disease through vaccination

    Pollard, Andrew J. (et al.)

    Pages 91-103

  • 207.00 lei

    Fully reviewed and revised for its second edition, the Oxford Handbook of Infectious Diseases and Microbiology maintains its position as the must-have guide to all aspects of infectious diseases and microbiology. Reflecting the current approach to joint postgraduate training programmes, the handbook takes an integrated approach to both subjects. It covers the basic principles of bacteriology and virology, along with specific guidance on individual diseases and conditions, all in the accessible Oxford Handbook style.

    Now including new topics on important subjects such as microbiology specimen collection, commonly used media, molecular diagnostics, and antimicrobials in pregnancy, as well as incorporating new guidelines from WHO, NICE, and BASHH among others, this handbook ensures that the informaiton you need is accessible, clear, and easy-to-understand.

    Practical and comprehensive, this handbook includes coverage of National Frameworks and current legislation, together with information on topical issues such as bioterrorism and preventative medicine. Fully reviewed by specialist senior readers, and with useful links to up-to-date clinical information and online resources, this is an important addition to the Oxford Handbook Series.


  • 40000lei 285.00 lei

     Transplant and oncology patients present a challenge to the infectious disease specialist because many of the entities that infect them are hard to diagnose.  Chemotherapy may further complicate the situation, since it may contraindicate a biopsy or interfere with antibiotic therapy. This issue of Infectious Disease Clinics provides specific information on several entities with the purpose of helping physicians to best treat these difficult infections.

  • Evidence-Based Neonatal Infections
    La comanda in aproximativ 4 saptamani
    34900lei 315.00 lei

    Evidence-Based Neonatal Infections is expertly written by David Isaacs, an experienced author renowned for his knowledge in both pediatric infections and evidence-based medicine. It critically analyses the evidence for decision making in neonatal infections. Evidence-Based Neonatal Infections * The first evidence-based text on neonatal infections * Provides practical guidance where evidence is poor * Complements David Isaacs Evidence-Based Pediatric Infectious Diseases (9781405148580) Practical and evidence-based, Evidence-Based Neonatal Infections is designed to help the clinician with day-to-day decisions on the care of newborn babies with possible, probable or proven infections. It considers clinical questions relevant to neonatologists, analysing the evidence carefully and providing recommendations for optimum management of neonatal infectious diseases, whilst reflecting on: * Efficacy and safety * Antibiotic resistance * Cost effectiveness * Adverse effects * Ethical considerations Evidence-Based Neonatal Infections provides a unique reference for neonatologists, pediatricians, trainees, specialist nurses; general practitioners, microbiologists, infection control doctors, and all staff in neonatal units.

  • Asthma and Infections
    La comanda in aproximativ 4 saptamani
    334.00 lei

    An invaluable resource, this book covers the full range of respiratory infections and explores the techniques used to detect the pathogens involved in asthma. Fifteen international experts representing the range of specialties involved in treating asthma examine the relationship between asthma and infection. They provide authoritative, time-tested guidance clinicians and researchers can utilize and trust. They cover bacterial and viral respiratory infections and pathogen detection, examining how microbes, infections, and antibiotic and anti-inflammatory agents affect asthma. The book helps readers identify the basic, translational, clinical aspects of asthma bacterial infection, inflammation, and allergic response. Not only does it present the facts but raises questions that will stimulate the clinical and research communities to explore new avenues that may provide clear answers to old questions.

  • Diagnosis of Fungal Infections
    La comanda in aproximativ 4 saptamani
    335.00 lei

    Analyzing a key cause of infectious morbidity in immunosuppressed and immunocompromised patients, this source spans the most recent strategies to improve and expedite the diagnosis, identification, and treatment of fungal infections.

    With authoritative contributions from experienced clinicians in the field, this reference tracks developments in imaging, susceptibility testing, and strain typing to combat these conditions in transplant, surgical, oncology, and intensive care units.

    Cover

    Half Title

    Infectious Disease and Therapy

    Title Page

    Copyright Page

    Preface

    Contents

    Contributors

      Part I: General Considerations of Diagnostic Methods in Systemic Fungal Infections

      1. Pearls in Establishing a Clinical Diagnosis: Signs and Symptoms

      2. The Role of Conventional Diagnostic Tools

      3. The Role of Radiology in the Diagnosis of Fungal Infections

      4. Serodiagnosis: Antibody and Antigen Detection

      5. Detection of Fungal Metabolites

      6. Molecular Diagnostics: Present and Future

      Part II: Diagnostic Approaches to Specific Fungal Infections

      7. Superficial and Mucosal Fungal Infections

      8. Invasive Mold Infections

      9. Invasive Yeast Infections

      10. Diagnosis of Cryptococcosis

      11. A Diagnostic Approach to Pneumocystis jiroveci Pneumonia

      12. The Diagnosis of Endemic Mycoses

      13. Hypersensitivity and Allergic Fungal Manifestations: Diagnostic Approaches

      Part III: Moving Forward: “Futuristic” Issues

      14. Molecular Mycology and Emerging Fungal Pathogens

    Index

    About the Editors

  • 39600lei 358.00 lei

    CONGENITAL AND PERINATAL INFECTIONS provides a concise and clinically-oriented primer on the congenital and perinatal infections likely to present in clinical practice. Written with the busy clinician in mind, it combines easy accessibility with state-of-the-art information on the epidemiology, pathogenesis, clinical manifestations, diagnosis, treatment, and prevention of congenital and perinatal infections.

    Eschewing the notion that congenital and perinatal infections only encompass agents from the TORCH group of pathogens, this volume offers comprehensive information on the spectrum of viral, bacterial, and parasitic infections that can manifest in mother or child. Combined with its brevity and emphasis on clinical management, CONGENITAL AND PERINATAL INFECTIONS is a definitive new guide to understanding this challenging group of infections.

  • 46300lei 415.00 lei

    Written by an international, interdisciplinary team of physicians, veterinarians, virologists, medical microbiologists, and parasitologists, Zoonoses: Infectious Diseases Transmissible from Animals to Humans covers zoonotic pathogens as agents of emergence and reemergence of zoonotic diseases, opportunistic zoonotic infections, risks of iatrogenic transmission and xenotransplantation, imported zoonotic infections, food-borne zoonoses, transmissible spongiform encephalopathies, and of warfare. Zoonoses is a valuable physician's reference that covers all aspects of epidemiology, diagnosis and differential diagnosis as well as therapy and prophylaxis of zoonotic diseases caused by bacteria, viruses, parasites, and fungi. Today, more than 200 diseases occurring in humans and animals are known to be mutually transmitted. Classic infectious diseases such as rabies, plague, and yellow fever have not been eradicated despite major efforts. New zoonotic diseases are appearing due to global conditions such as overpopulation, wars, and food scarcity, which facilitate human contact with rodents, stray animals, and their parasites. In addition, humans are unwittingly becoming accidental hosts and new links in an infectious chain by engaging in activities such as survival training, which involves camping in open areas, and consumption of raw or insufficiently cooked food. Zoonotic infections cause a variety of symptoms that often do not provide clear evidence of a known disease. Zoonoses, Fourth Edition, describes most occurring worldwide zoonoses and facilitates the identification, diagnosis, and treatment of zoonotic infections. Written by a team of doctors, medical microbiologists and veterinarians, this revised and updated edition—translated from the noted German reference Zoonosen—covers all aspects of the epidemiology and prevention of zoonotic diseases supported by clear descriptions of various illnesses. Specifically, this fourth edition covers zoonoses caused by: • Viruses, bacteria, fungi, and parasites • infections caused by animal bites • infections and intoxications by animal foods • iatrogenic transmission of zoonotic pathogens

  • 46700lei 421.00 lei

    This book aims to fill knowledge gap among healthcare workers about Clostridium difficile (also known as C.difficile and CDI) among aging patients, especially those in long-term care facilities (LTCFs).  Written by experts in infectious diseases and geriatric medicine, this book provides comprehensive information on all aspects of CDI pertaining to LTCF settings, including epidemiology, diagnosis, prevention, management and the unique challenges faced by LTCFs with regards to the CDI problem.

    The book begins by introducing the topic as it relates to aging patients before delving into the various aspects of CDI management.  Topics include infection control and prevention, treatment of CDI, and the establishment of antibiotic stewardship programs to reduce inappropriate antibiotic use and reduce CDI rates. The book also features a chapter on probiotics for the prevention of CDI and new strategies to monitor environmental cleaning practices of CDI patient rooms that do not appear in any other resource.

    Clostridium Difficile Infection in Long-Term Care Facilities is an excellent resource for geriatricians, infectious diseases specialists, long-term care administrators, nurses, pharmacists, researchers, and all clinicians working with infections in long-term care settings.

    Cover

    Front Matter

      1. Introduction

      2. Epidemiology of Clostridioides difficile Infection in Long-Term Care Facilities

      3. Role of Asymptomatic Carriers in Long-Term Care Facility Clostridioides (Clostridium) difficile Transmission

      4. Clostridium difficile (Clostridioides difficile) Infection Surveillance in Long-Term Care Facilities

      5. Clostridium difficile Diagnostics in Long-Term Care Facilities

      6. Control of Clostridium (Clostridioides) difficile Infection in Long-Term Care Facilities/Nursing Homes

      7. Antibiotic Stewardship Related to CDI in Long-Term Care Facilities

    Back Matter

  • 48700lei 440.00 lei

    Written by an international team of authors specializing in microbiology and infectious disease, this new edition of Evidenced-based Infectious Diseases presents practical, up-to-date information on the care of individual patients suffering from infectious diseases. Each chapter addresses a series of focused clinical questions addressed in a systematic fashion, including a comprehensive literature search, and a rating of the quality of evidence using principles of the GRADE framework. Evidence-Based Infectious Diseases is the ideal reference work for all those involved with microbiology, infectious diseases, and clinical management. 

    Table of contents

    List of Contributors vii

    Preface xi

    1 Introduction to Evidence‐based Infectious Diseases 1

    Dominik Mertz, Nick Daneman, and Fiona Smaill

    Part 1 Specific Diseases 11

    2 Skin and Soft‐tissue Infections 13

    Douglas Austgarden and Guilio DiDiodato

    3 Bone and Joint Infections 23

    Nora Renz and Andrej Trampuz

    4 Infective Endocarditis 37

    Bahareh Ghadaki and Deborah Yamamura

    5 Meningitis and Encephalitis 53

    Christopher E. Kandel and Wayne L. Gold

    6 Community‐acquired Pneumonia 73

    Mark Downing and Jennie Johnstone

    7 Healthcare‐associated Pneumonia 81

    Jennie Johnstone and Mark Downing

    8 Tuberculosis 87

    Peter Daley and Marek Smieja

    9 Clostridium Difficile Infection in Adults 99

    Louis Valiquette

    10 Urinary Tract Infections 107

    Thomas Fekete

    11 Sexually Transmitted Infections 127

    Courtney A. Thompson, Darrell H. S. Tan, and Kaede Sullivan

    12 Human Immunodeficiency Virus (HIV) 149

    Ali Amini, Monique Andersson, Ravindra Gupta, and Brian Angus

    13 Hepatitis 181

    Lise Bondy and Michael S. Silverman

    14 Influenza 193

    Ashley Roberts and Joanne M. Langley

    15 Critical Care 201

    Bram Rochwerg and Jocelyn A. Srigley

    Part 2 Special Populations 215

    16 Infection Prevention and Control 217

    Graham M. Snyder and Eli N. Perencevich

    17 Antimicrobial Stewardship 235

    Alainna J. Jamal and Andrew M. Morris

    18 Infections in Neutropenic Hosts 251

    Eric J. Bow

    19 Infections in General Surgery 269

    Paul A. Moroz and Christine H. Lee

    20 Infections in Healthcare Workers 279

    Gregory W. Rose

    Index 287

  • 49500lei 445.00 lei

    This book is designed to present a comprehensive and state-of the-art update that covers the pathophysiology, epidemiology, and clinical presentation of the most frequently encountered STIs in adolescence and young adulthood. The introductory sections discuss more general themes including approaches to obtaining a sexual history and exam, concerns of sexual minority youth, ethical and legal considerations, and health disparities in STIs in this population. Subsequent chapters are organized by pathogen such as herpes simplex virus, and human immunodeficiency virus, or clinical syndrome including pelvic inflammatory disease, and vaginitis. Each chapter begins with a case study to illustrate key characteristics of the disease process in question and includes rich illustrations, resources, and guidelines. Written by experts in the field, the text includes a review of epidemiology, pathophysiology, treatment, prevention, and adolescent-specific considerations that is vital to working with this important population.

  • Hepatitis C Virus Treatment
    Ultima bucata in stoc
    53100lei 475.00 lei

    This book introduces readers to Direct Acting Antiviral (DAAs) agents, newly developed drugs to treat chronic hepatitis C virus infection, which have an excellent anti-viral effect on virus replication. These drugs have been developed to enhance the effect of interferon and ribavirin, as the resistant strains against each drug have been described both in vitro and in vivo and the existences of naturally occurring variants have been reported. However, since the combination of different classes of DAAs is sufficient to completely eradicate the virus without the need for interferon or ribavirin, the current treatment regimen does not include interferon. Ribavirin is used in combination with sofosbuvir, a potent polymerase inhibitor, to enhance its antiviral effects.

    Hepatitis C Virus Treatment offers readers a comprehensive guide to hepatitis C; describing the resistance profiles against these drugs and shedding light on the difficulties involved in DAA therapy and the direction of future treatments, it will equip doctors to understand the essentials of treating the disease. It also describes in detail new and innovative DAA treatments, the effects of the agents, and the characteristics of resistance, providing cutting-edge information not only for hepatologists, but also for researchers, clinical residents, and medical students.

  • 53100lei 475.00 lei

    This volume serves as a reference for the dissemination of advances made in the study of Hepatitis B Virus (HBV). Hepatitis B Virus: Methods and Protocols details protocols and techniques ranging from cell culture studies to in vivo and clinical immunology. The chapters in this book discuss treatments of in vitro infection systems, analysis and quantification of cccDNA and its mutations; in vitro polymerase activity assays; cellular trafficking of core proteins; intracellular calcium metabolism; detection, cloning, and sequencing of HBV markers; and new strategies aimed at exploiting new mechanisms for drug discovery. The book also covers classical methods for resolution of extracellular viral particles by native gel electrophoresis, and methods for detecting HBV antigens in drug discovery. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.

    Cutting-edge and comprehensive, Hepatitis B Virus: Methods and Protocols is a valuable tool for researchers to use toward their advanced studies in HBV.

  • 59700lei 525.00 lei

    Vulvovaginal Infections presents new knowledge to help clinicians accurately diagnose and treat their patients and highlights for researchers remaining unsolved problems and the most promising areas for continued investigation. Clinical gynecologists will find practical advice and extensive insight into solving real-life clinical scenarios. The book opens by presenting information on the microbiology of the vagina and vaginal immunology. It then discusses the diagnosis of vulvovaginal disease, including physical examination, screening processes, and laboratory testing. Diagnosis is followed by covering various vulvovaginal infections including bacterial vaginosis, Candida vulvovaginitis, Trichomonas vaginalis vaginitis, genital herpes, human papillomavirus genital infections, allergic vulvovaginitis, menopausal vulvovaginitis, cytolytic vaginosis, aerobic vaginitis, and more. For each of these conditions, the book presents information on its background, microbiology, immunology, prevention, diagnosis, and treatment. Therapy details are provided with an emphasis on nuances that can be applied to women who fail to respond to medication prescribed or who respond and then become symptomatic once treatment has ended. This new edition discusses major advances in the characterization of endogenous microbiota that populate the genital tract in women of all ages. It also provides a more sophisticated appreciation of immune mechanisms found in the healthy female genital tract and alterations that increase both susceptibility and consequences of various infectious and noninfectious disorders. A major impetus for writing this new edition is to help the busy clinician, resident, or fellow by explaining advances in individual disorders in a manner that is relevant to their practice.

  • 61700lei 545.00 lei

    There are approximately 4 million newborns annually in the United States, including 400,000 infants born preterm.  This care occurs in nurseries of all acuity levels, sizes, and regions across the country and is provided by a variety of providers, including pediatricians, family practice doctors, nurse practitioners, and physician assistants.  The most common complication during the newborn period is suspected or proven infection – either those acquired during the delivery itself or before delivery in the womb.  Indeed, 4 of the 8 most commonly-prescribed medications in newborns annually are antibiotics. Therefore, these providers must all be knowledgeable about the clinical presentation, epidemiology, and approach to diagnosis, treatment and prevention of neonatal infections.  However, many of these nurseries do not have convenient access to pediatric infectious disease consultation or support, and would benefit from a convenient reference guide.

    This book effectively and succinctly covers the pathophysiology, epidemiology, clinical presentation, approach to diagnosis and treatment, and important aspects of preventative care for the most frequently encountered neonatal and congenital infections.  The first section discusses common neonatal infections (i.e., those acquired during or after delivery), including sepsis, meningitis, pneumonia, and other focal infections.  The second section covers the most frequently encountered congenital infections (i.e., those acquired via the placenta while the fetus is still in-utero).  Finally, the concluding section discusses the basics of infection prevention in the nursery setting, including general principles of infection prevention, how to apply those principles to families, and how to manage a suspected outbreak of infection within a nursery.

    This book is a unique contribution to the field. Existing texts such as the AAP Red Book fold neonatal infections in within chapters on a given pathogen, but the information is difficult to find and access quickly.  By covering neonatal and congenital infections thoroughly while still keeping each section clear and concise, this Handbook will be a valuable resource for the busy nursery provider.

  • 66900lei 588.00 lei

    With the rapid development of economy and international communication, world population mobility increase significantly. As migrating population is one of vulnerable populations to infectious diseases, strengthening monitoring system and intervention approaches will be a key factor in controlling the spread of infectious diseases.

    This book is intended to provide valuable information on creating effective prevention and intervention strategies of tuberculosis, taking Shenzhen, one of typical immigrant cities, as an example.

    Followed by overview of tuberculosis, the control strategy, diagnosis and treatment of tuberculosis, drug resistant tuberculosis, and HIV-associated tuberculosis in migrating population is introduced. In addition, application of innovative technologies, for example, internet, molecular biology, and artificial intelligence in tuberculosis control is presented. It will be a useful reference for practitioners in centers for infectious disease control and prevention, hospitals, academic institutions, as well as staff in government agencies and non-government organizations with interests in tuberculosis prevention and control.

    Cover

    Front Matter

      1. Overview of Tuberculosis

      2. Epidemiology of Tuberculosis in Migrating Population

      3. Strategy of TB Control in Migrating Population

      4. Prevention, Diagnosis, and Treatment of TB in the Migrating Population

      5. Management of Migrating Population with Tuberculosis

      6. TB Control in Schools

      7. Control of Drug-Resistant TB

      8. Control of TB/HIV Coinfection

      9. New Technologies for TB Control in Migrating Population

      10. Emergency Management of TB Emergency Public Health Events

  • 76000lei 670.00 lei

    The Oxford Textbook of Medical Mycology is a comprehensive reference text which brings together the science and medicine of human fungal disease. Written by a leading group of international authors to bring a global expertise, it is divided into sections that deal with the principles of mycology, the organisms, a systems-based approach to management, fungal disease in specific patient groups, diagnosis, and treatment.

    The detailed clinical chapters take account of recent international guidelines on the management of fungal disease. With chapters covering recent developments in taxonomy, fungal genetics and other "omics", epidemiology, pathogenesis, and immunology, this textbook is well suited to aid both scientists and clinicians.

    The extensive illustrations, tables, and in-depth coverage of topics, including discussion of the non-infective aspects of allergic and toxin mediated fungal disease, are designed to aid the understanding of mechanisms and pathology, and extend the usual approach to fungal disease.

    This textbook is essential reading for microbiologists, research scientists, infectious diseases clinicians, respiratory physicians, and those managing immunocompromised patients. Part of the Oxford Textbook in Infectious Disease and Microbiology series, it is also a useful companion text for students and trainees looking to supplement mycology courses and microbiology training.

  • Water-Associated Infectious Diseases
    La comanda in aproximativ 4 saptamani
    78600lei 690.00 lei

    This book provides a comprehensive overview of the different water-associated infectious diseases and their linked pathogens with plausible strategies for their mitigation. Although, we are in the era of 21st century having most of the advanced technologies at hand, yet water-associated infectious diseases are the major contributors towards the worldwide morbidity and mortality.

    The book also focuses on the various implementation strategies of sustainable hygienic conditions, discusses the robust, and reliable policies and strategies on a global aspect to provide unprivileged people access to the basic sanitation, hygiene and water. In addition, the book discusses the possible indirect effect of global warming on the spread of infectious diseases through the distribution of associated vectors.

    Cover

    Front Matter

      1. Introduction to Water-Associated Infectious Diseases

      2. Etiological Agents of Water-Associated Infectious Diseases

      3. Evolution and Interplay of Water-Associated Human Pathogens

      4. Epidemiology of Water-Associated Infectious Diseases

      5. Emerging and Re-emerging Water-Associated Infectious Diseases

      6. Impact of Climate Change on Water-Associated Infectious Diseases

      7. Hazards Associated with Contaminated Water

      8. Global Strategies and Schemes for Preventing Water-Associated Infectious Diseases

      9. Novel Approaches for Detecting Water-Associated Pathogens

      10. Treatment of Water to Prevent Water-Associated Infectious Diseases

      11. Conventional Treatments of Water-Associated Infectious Diseases

      12. Complementary and Alternative Medicine Treatments of Water-Associated Infectious Diseases

  • 78200lei 705.00 lei

    Description

    The fourth edition of this best-selling Red Book® image companion aids in the diagnosis and treatment of more than 160 of the most commonly seen pediatric infectious diseases. This edition features Zika virus, chikungunya, serious bacterial infections caused by Enterobacteriaceae, Moraxella catarrhalis, human parechovirus, rhinovirus, staphylococcal food poisoning, Staphylococcus aureus, coagulase-negative staphylococcal infections, Ureaplasma urealyticum, and Ureaplasma parvum.

     

    Streamline disease recognition and clinical decision-making with hundreds of finely detailed color images, combined with updated step-by-step guidelines.

     

    Concise text descriptions walk the reader through the diagnosis, evaluation, and management essentials for each condition.

     

    • Clinical manifestations
    • Epidemiology
    • Diagnostic tests
    • Etiology
    • Incubation period
    • Treatment

     

    Contents include:

    • Adenovirus Infections
    • Bacteroides and Prevotella Infections
    • Candidiasis
    • Cystosporiasis (formerly Isosporiasis)
    • Epstein-Barr Virus Infections (Infectious Mononucleosis)
    • Human Herpesvirus 6 (including Roseola) and 7
    • Lyme Disease (Lyme borreliosis, Borrelia burgdorferi Infection)
    • Meningococcal Infections
    • Human Papillomaviruses
    • Pelvic inflammatory disease
    • Pneumococcal Infections
    • Respiratory Syncytial Virus
    • Group A Streptococcal Infections
    • Staphylococcus aureus
    • Plus much more...

  • Infectious Diseases and Nanomedicine II
    La comanda in aproximativ 4 saptamani
    86500lei 735.00 lei

    The book addresses the interdisciplinary scientific approach for the systemic understanding of connections between major human diseases and their treatment regime by applying the tools and techniques of nanotechnology. It also highlights the interdisciplinary collaborative researches for innovation in Biomedical Sciences. The book is a second volume which presents collection of best papers presented in the First International Conference on Infectious Diseases and Nanomedicine held during Dec. 15-18, 2012 in Kathmandu, Nepal.

  • Infectious Diseases and Nanomedicine I
    La comanda in aproximativ 4 saptamani
    87500lei 745.00 lei

    The book addresses the interdisciplinary scientific approach for the systemic understanding of connections between major human diseases and their treatment regime by applying the tools and techniques of nanotechnology. It also highlights the interdisciplinary collaborative researches for innovation in Biomedical Sciences. The book is a first volume which presents collection of best papers presented in the First International Conference on Infectious Diseases and Nanomedicine held during Dec. 15-18, 2012 in Kathmandu, Nepal.

  • 99300lei 849.00 lei

    Description:
    Regarded as the definitive source of information in the field, Infectious Diseases of the Fetus and Newborn Infant remains your indispensable source for authoritative, state-of-the-art answers. Edited by Drs. Wilson, Nizet, Maldonado, Remington, and Klein, this fully updated reference helps you apply the latest evidence-based recommendations in the prevention, diagnosis, and management of infections found in utero, during delivery, and in the neonatal period in both premature and term infants.

    Features:
    • Form a definitive diagnosis and create the best treatment plans possible using evidence-based recommendations and expert guidance from world authorities.
    • Locate key content easily and identify clinical conditions quickly thanks to a consistent, highly user-friendly format now featuring a full-color design with hundreds of illustrations, and fresh perspectives from six new authoritative chapter lead authors.
    New To This Edition:
    • Explore what’s changing in key areas such as: - emerging problems and concepts in maternal, fetal, and neonatal infectious diseases - anticipation and recognition of infections occurring in utero, during delivery, and in the neonatal period
    • Stay on the cutting edge of your field with new and improved chapters including: obstetric factors associated with infections of the fetus and newborn infant; human milk; borella infections; tuberculosis; bordetella pertussis and other bordetella sp infections; herpes simplex; toxoplasmosis; pneumocystis and other less common fungal infections; and healthcare-associated infections in the nursery
    • Keep up with the most relevant topics in fetal/neonatal infectious disease including new antimicrobial agents, gram- negative infections and their management, and recommendations for immunization of the fetus/mother.
    • Overcome clinical challenges in developing countries where access to proper medical care is limited.
    • Expert Consult eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, references, and videos from the book on a variety of devices.

  • 1,00800lei 875.00 lei

     

    DESCRIPTION

     

    The most practice-oriented guide to diagnosing and managing infectious diseases in children.

    Pediatric Infectious Diseases: Essentials for Practice, Second Edition is filled with practical, clinically relevant guidance for successful infectious disease management. The care of the patient forms the core of this indispensable resource, which also provides perspectives on epidemiology, pathophysiology, and diagnosis that every pediatrician, pediatric hospitalist, and pediatric nurse practitioner needs to know. The book's high-yield coverage includes detailed, yet precise overviews of specific infections and their etiology, along with proven diagnostic and management strategies that readers can incorporate into their practice right away.

     

    FEATURES:

     

    • Tips that tell you what you must know--and do--at every stage of care

     

    • Diagnostic and treatment algorithms

     

    • Signs/Symptoms and Differential Diagnosis boxes

     

    • "When to Refer" boxes, which examine all the relevant clinical considerations

     

    • Diagnostic Tests--with a realistic emphasis on the right tests to order

     

    • Medical Treatment coverage that includes drugs, dosages, and administration in an easy-to-read tabular format

     

    • Convenient icons and a templated chapter design

     

    • Numerous clinical color photos and didactic diagrams

     

    • NEW! Clinical Pearls boxes accompany coverage of each infectious disease

     

    • Updated treatment guidelines and protocols from the CDC

     

    If you are in need of an up-to-date, clinically relevant guide to treating infectious diseases in pediatric patients, your search ends here.

     

    TABLE OF CONTENTS

    Section 1. Practical Aspects

    1Clinical Microbiology

    2Clinical Virology

    3Active immunization, passive immunization and chemoprophylaxis

    4Office infection control (daycare)

    5Hospital infection control6Infectious Diseases Epidemiology

    Section 2 Signs and Symptoms

    7Chronic Abdominal Pain

    8Ataxia

    9Dysuria

    10Headache

    11Joint Complaints

    12Neck pain

    13Rash 

    14Stridor

    15Wheezing

    Section 3 Infections of Organ Systems

    Part A Neurologic Infections

    16Meningitis

    17Encephalitis

    18Transverse myelitis

    19Movement disorders

    Part B Ophthalmologic Infections

    20Conjunctivitis in the neonate

    21Conjunctivitis in the older child

    22Periorbital and orbital infections

    23Keratitis

    Part C Oral Cavity and Neck Infections

    24Pharyngitis and stomatitis

    25Peritonsillar and retropharyngeal abscess

    26Cervical lymphadenitis

    27Gingival and Periodontal Infections

    Part D Upper Respiratory Infections

    28Otitis media

    29Otitis externa

    30Rhinosinusitis

    31Croup

    Part E Lower Respiratory Infections

    32Bronchiolitis

    33Uncomplicated pneumonia

    34Complicated pneumonia

    35Recurrent pneumonia

    36Childhood tuberculosis 

    Part F Cardiac Infections

    37Endocarditis

    38Myocarditis and Pericarditis

    39Acute rheumatic fever

    Part G Gastrointestinal Infections

    40Gastroenteritis

    41Hepatitis

    42Antibiotic-associated diarrhea

    Part H Genitourinary Infections

    43Urinary tract infections

    44Pelvic inflammatory diseases

  • 1,26000lei 1075.00 lei

    Trusted by physicians and advanced practice providers through ten standard-setting editions, Fanaroff and Martin's Neonatal-Perinatal Medicine, 11th Edition, remains the reference of choice for expert, multidisciplinary guidance on the management and evidence-based treatment of problems in the mother, fetus, and neonate. An expanded team of international authors, led by Drs. Richard J. Martin, Avroy A. Fanaroff, and Michele C. Walsh of Rainbow Babies and Children's Hospital, brings you up to date with advances in the control of nosocomial infections in preterm infants, genetic disorders and birth defects, the fetal origins of adult disease, the late preterm infants, and much more - all designed to help you improve the quality of life and long-term outcomes of your patients. Helps you make informed clinical choices for each patient - from diagnosis and treatment selection through post-treatment strategies and management of complications - with a dual focus on neonatology and perinatology. Includes a new chapter on Social and Economic Contributors to Neonatal Outcome. Features extensive updates and reorganization throughout, with new Key Points at the end of each chapter Provides up-to-date, evidence-based content, with more information on precision medicine and genetics. Uses detailed, full-color illustrations that depict disorders in the clinical setting and explain complex information. Offers indexing in both volumes that provides quick access to specific guidance. Remains the most comprehensive, multidisciplinary text in the field - an excellent source of information for every stage of your practice. Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.

  • 1,28600lei 1100.00 lei

    Includes a revised taxonomic outline for the Actinobacteria or the high G+C Gram positives is based upon the SILVA project as well as a description of greater than 200 genera in 49 families. Includes many medically and industrially important taxa.

  • 1,51300lei 1290.00 lei

    Drs. Cohen, Powderly and Opal, three of the most-respected names in infectious disease medicine, lead a diverse team of international contributors to bring you the latest knowledge and best practices. Extensively updated, the fourth edition includes brand-new information on advances in diagnosis of infection; Hepatitis C; managing resistant bacterial infections; and many other timely topics. An abundance of photographs and illustrations; a practical, clinically-focused style; highly-templated organization; and robust interactive content combine to make this clinician-friendly resource the fastest and best place to find all of the authoritative, current information you need.

    New to this edition
    • Sweeping updates include new or revised chapters on:
      •  

      • Hepatitis C and antivirals
      •  

         

      • Fungal infection and newer antifungals
      •  

         

      • Microbiome and infectious diseases as well as advances in diagnosis of infection; Clostridium difficile epidemiology; infection control in the ICU setting; Chlamydia trachomatis infection; acquired syndromes associated with autoantibodies to cytokines;; management of multidrug resistant pathogens; probiotics, polymyxins, and the pathway to developing new antibiotics
      •  

         

      • HIV including HIV and aging, antiretroviral therapy in developing countries, and cure for HIV.

       

       

    • Online Antimicrobial pharmacokinetics mannequin, as well an all new HIV medicine mannequin are a useful visual source of treatment information

  • 1,58500lei 1345.00 lei

    Tropical Infectious Diseases: Principles, Pathogens and Practice, by Drs. Richard L. Guerrant, David H. Walker, and Peter F. Weller, delivers the expert, encyclopedic guidance you need to overcome the toughest clinical challenges in diagnosing and treatin

  • 1,55400lei 1365.00 lei

     •             Includes complete information for each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, epidemiology, and public health and regulatory issues - plus complete information for each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.

                 Analyzes the cost-benefit and cost-effectiveness of different vaccine options.

                 Helps you clearly visualize concepts and objective data through an abundance of tables and figures.

    New To This Edition:

                 Covers the new oral cholera and zoster vaccines, as well as newly licensed meningococcal group B vaccines and a newly licensed dengue vaccine.

                 Brings you up to date on successful human trials of Ebola vaccines, an enterovirus 71 vaccine licensed in China, and new recommendations and changes to polio vaccines.

                 Features a new chapter on maternal immunization.

                 Expert Consult™ eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices.

  • 2,04800lei 1745.00 lei

    Description:

    For four decades, physicians and other healthcare providers have trusted Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases to provide expert guidance on the diagnosis and treatment of these complex disorders. The 9th Edition continues the tradition of excellence with newly expanded chapters, increased global coverage, and regular updates to keep you at the forefront of this vitally important field. Meticulously updated by Drs. John E. Bennett, Raphael Dolin, and Martin J. Blaser, this comprehensive, two-volume masterwork puts the latest information on challenging infectious diseases at your fingertips.

    Table Of Contents:

    I Basic Principles in the Diagnosis and Management of Infectious Diseases
    A MICROBIAL PATHOGENESIS
    1 A Molecular Perspective of Microbial Pathogenicity
    2 The Human Microbiome of Local Body Sites and Their Unique Biology
    3 Prebiotics, Probiotics, and Synbiotics
    B HOST DEFENSE MECHANISMS
    4 Innate (General or Nonspecific) Host Defense Mechanisms
    5 Adaptive Immunity: Antibodies and Immunodeficiencies
    6 Cell-Mediated Defense Against Infection
    7 Mucosal Immunity
    8 Granulocytic Phagocytes
    9 Complement and Deficiencies
    10 Human Genetics and Infection
    11 Nutrition, Immunity, and Infection
    12 Evaluation of the Patient With Suspected Immunodeficiency
    C EPIDEMIOLOGY OF INFECTIOUS DISEASE
    13 Applied Epidemiology for the Infectious Diseases Physician
    14 Emerging and Reemerging Infectious Disease Threats
    15 Bioterrorism: An Overview
    D CLINICAL MICROBIOLOGY
    16 The Clinician and the Microbiology Laboratory: Test Ordering, Specimen Collection, and Result Interpretation
    E ANTIINFECTIVE THERAPY
    17 Principles of Antiinfective Therapy
    18 Molecular Mechanisms of Antibiotic Resistance in Bacteria
    19 Pharmacokinetics and Pharmacodynamics of Antiinfective Agents
    20 Penicillins and ß-Lactamase Inhibitors
    21 Cephalosporins
    22 Ertapenem, Imipenem, Meropenem, Doripenem, and Aztreonam
    23 Antibiotic Allergy
    24 Fusidic Acid
    25 Aminoglycosides
    26 Tetracyclines, Glycylcyclines, and Chloramphenicol
    27 Rifamycins
    28 Metronidazole
    29 Macrolides and Clindamycin
    30 Glycopeptides (Vancomycin and Teicoplanin) and Lipoglycopeptides (Telavancin, Oritavancin, and Dalbavancin)
    31 Daptomycin and Quinupristin-Dalfopristin
    32 Polymyxins (Polymyxin B and Colistin)
    33 Linezolid, Tedizolid, and Other Oxazolidinones
    34 Sulfonamides and Trimethoprim; Trimethoprim-Sulfamethoxazole
    35 Quinolones
    36 Unique Antibacterial Agents
    37 Urinary Tract Agents: Nitrofurantoin, Fosfomycin, and Methenamine
    38 Topical Antibacterials
    39 Antimycobacterial Agents
    40A Antifungal Agents: Amphotericin B
    40B Antifungal Drugs: Azoles
    40C Antifungal Drugs: Echinocandins
    40D Antifungal Drugs: Flucytosine
    41 Antimalarial Drugs
    42 Drugs for Protozoal Infections Other Than Malaria
    43 Drugs for Helminths
    44 Antiviral Agents: General Principles
    45 Antiviral Drugs for Influenza and Other Respiratory Virus Infections
    46 Antivirals Against Herpesviruses
    47 Antiviral Drugs Against Hepatitis Viruses
    48 Miscellaneous Antiviral Agents (Interferons, Tecovirimat, Imiquimod, Pocapavir, Pleconaril)
    49 Immunomodulators
    50 Hyperbaric Oxygen
    51 Antimicrobial Stewardship
    52 Designing and Interpreting Clinical Studies in Infectious Diseases
    53 Outpatient Parenteral Antimicrobial Therapy
    54 Tables of Antiinfective Agent Pharmacology
    II Major Clinical Syndromes
    A FEVER
    55 Temperature Regulation and the Pathogenesis of Fever
    56 Fever of Unknown Origin
    57 The Acutely Ill Patient With Fever and Rash
    B UPPER RESPIRATORY TRACT INFECTIONS
    58 The Common Cold
    59 Pharyngitis
    60 Acute Laryngitis
    61 Otitis Externa, Otitis Media, and Mastoiditis
    62 Sinusitis
    63 Epiglottitis
    64 Infections of the Oral Cavity, Neck, and Head
    C PLEUROPULMONARY AND BRONCHIAL INFECTIONS
    65 Acute Bronchitis
    66 Acute Exacerbations of Chronic Obstructive Pulmonary Disease
    67 Acute Pneumonia
    68 Pleural Effusion and Empyema
    69 Bacterial Lung Abscess
    70 Chronic Pneumonia
    71 Cystic Fibrosis
    D URINARY TRACT INFECTIONS
    72 Urinary Tract Infections
    E SEPSIS
    73 Sepsis and Septic Shock
    F INTRAABDOMINAL INFECTIONS
    74 Peritonitis and Intraperitoneal Abscesses
    75 Infections of the Liver and Biliary System (Liver Abscess, Cholangitis, Cholecystitis)
    76 Pancreatic Infection
    77 Splenic Abscess
    78 Appendicitis
    79 Diverticulitis and Neutropenic Enterocolitis
    G CARDIOVASCULAR INFECTIONS
    80 Endocarditis and Intravascular Infections
    81 Prosthetic Valve Endocarditis
    82 Infections of Nonvalvular Cardiovascular Devices
    83 Prevention of Infective Endocarditis
    84 Myocarditis and Pericarditis
    85 Mediastinitis
    H CENTRAL NERVOUS SYSTEM INFECTIONS
    86 Approach to the Patient With Central Nervous System Infection
    87 Acute Meningitis
    88 Chronic Meningitis
    89 Encephalitis
    90 Brain Abscess
    91 Subdural Empyema, Epidural Abscess, and Suppurative Intracranial Thrombophlebitis
    92 Cerebrospinal Fluid Shunt and Drain Infections
    I SKIN AND SOFT TISSUE INFECTIONS
    93 Cellulitis, Necrotizing Fasciitis, and Subcutaneous Tissue Infections
    94 Myositis and Myonecrosis
    95 Lymphadenitis and Lymphangitis
    J GASTROINTESTINAL INFECTIONS AND FOOD POISONING
    96 Syndromes of Enteric Infection
    97 Esophagitis
    98 Diarrhea With Little or No Fever
    99 Acute Dysentery Syndromes (Diarrhea With Fever)
    100 Typhoid Fever, Paratyphoid Fever, and Typhoidal Fevers
    101 Foodborne Disease
    102 Tropical Sprue and Environmental Enteric Dysfunction
    K BONE AND JOINT INFECTIONS
    103 Infectious Arthritis of Native Joints
    104 Osteomyelitis
    105 Orthopedic Implant-Associated Infections
    L DISEASES OF THE REPRODUCTIVE ORGANS AND SEXUALLY TRANSMITTED DISEASES
    106 Genital Skin and Mucous Membrane Lesions
    107 Urethritis
    108 Vulvovaginitis and Cervicitis
    109 Infections of the Female Pelvis
    110 Prostatitis, Epididymitis, and Orchitis
    M EYE INFECTIONS
    111 Introduction to Eye Infections
    112 Microbial Conjunctivitis
    113 Microbial Keratitis
    114 Endophthalmitis
    115 Infectious Causes of Uveitis
    116 Periocular Infections
    N HEPATITIS
    117 Viral Hepatitis
    O ACQUIRED IMMUNODEFICIENCY SYNDROME
    118 Global Perspectives on Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome
    119 Epidemiology and Prevention of AIDS and HIV Infection, Including Preexposure Prophylaxis and HIV Vaccine Development
    120 Diagnosis of Human Immunodeficiency Virus Infection
    121 The Immunology of Human Immunodeficiency Virus Infection
    122 General Clinical Manifestations of Human Immunodeficiency Virus Infection (Including Acute Retroviral Syndrome and Oral, Cutaneous, Renal, Ocular, Metabolic, and Cardiac Diseases)
    123 Pulmonary Manifestations of Human Immunodeficiency Virus Infection
    124 Gastrointestinal, Hepatobiliary, and Pancreatic Manifestations of Human Immunodeficiency Virus Infection
    125 Neurologic Diseases Caused by Human Immunodeficiency Virus Type 1 and Opportunistic Infections
    126 Human Immunodeficiency Virus Infection in Women
    127 Pediatric Human Immunodeficiency Virus Infection
    128 Antiretroviral Therapy for Human Immunodeficiency Virus Infection
    129 Management of Opportunistic Infections Associated With Human Immunodeficiency Virus Infection
    P MISCELLANEOUS SYNDROMES
    130 Chronic Fatigue Syndrome (Systemic Exertion Intolerance Disease)
    III Infectious Diseases and Their Etiologic Agents
    A VIRAL DISEASES
    131 Biology of Viruses and Viral Diseases
    132 Orthopoxviruses Vaccinia (Smallpox Vaccine), Variola (Smallpox), Monkeypox, and Cowpox
    133 Other Poxviruses That Infect Humans: Parapoxviruses (Including Orf Virus), Molluscum Contagiosum, and Yatapoxviruses
    134 Introduction to Herpesviridae
    135 Herpes Simplex Virus
    136 Chickenpox and Herpes Zoster (Varicella-Zoster Virus)
    137 Cytomegalovirus
    138 Epstein-Barr Virus (Infectious Mononucleosis, Epstein-Barr Virus-Associated Malignant Diseases, and Other Diseases)
    139 Human Herpesvirus Types 6 and 7 (Exanthem Subitum)
    140 Kaposi Sarcoma-Associated Herpesvirus (Human Herpesvirus 8)
    141 Herpes B Virus
    142 Adenoviruses
    143 Papillomaviruses
    144 JC, BK, and Other Polyomaviruses: Progressive Multifocal Leukoencephalopathy (PML)
    145 Hepatitis B Virus
    146 Hepatitis Delta Virus
    147 Human Parvoviruses, Including Parvovirus B19V and Human Bocaparvoviruses
    148 Orthoreoviruses and Orbiviruses
    149 Coltiviruses (Colorado Tick Fever Virus) and Seadornaviruses
    150 Rotaviruses
    151 Alphaviruses (Chikungunya, Eastern Equine Encephalitis)
    152 Rubella Virus (German Measles)
    153 Flaviviruses (Dengue, Yellow Fever, Japanese Encephalitis, West Nile Encephalitis, Usutu Encephalitis, St. Louis Encephalitis, Tick-Borne Encephalitis, Kyasanur Forest Disease, Alkhurma Hemorrhagic Fever, Zika)
    154 Hepatitis C
    155 Coronaviruses, Including Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS)
    156 Parainfluenza Viruses
    157 Mumps Virus
    158 Respiratory Syncytial Virus
    159 Human Metapneumovirus
    160 Measles Virus (Rubeola)
    161 Zoonotic Paramyxoviruses: Nipah, Hendra, and Menangle Viruses
    162 Vesicular Stomatitis Virus and Related Vesiculoviruses (Chandipura Virus)
    163 Rabies (Rhabdoviruses)
    164 Marburg and Ebola Virus Hemorrhagic Fevers
    165 Influenza Viruses, Including Avian Influenza and Swine Influenza
    166 California Encephalitis, Hantavirus Pulmonary Syndrome, Hantavirus Hemorrhagic Fever With Renal Syndrome, and Bunyavirus Hemorrhagic Fevers
    167 Lymphocytic Choriomeningitis Virus, Lassa Virus, and the South American Hemorrhagic Fevers (Arenaviruses)
    168 Human T-Cell Leukemia Viruses (HTLV-1, HTLV-2)
    169 Human Immunodeficiency Viruses
    170 Introduction to the Human Enteroviruses and Parechoviruses
    171 Poliovirus
    172 Coxsackieviruses, Echoviruses, and Numbered Enteroviruses (EV-A71, EVD-68, EVD-70)
    173 Parechoviruses
    174 Hepatitis A Virus
    175 Rhinovirus
    176 Noroviruses and Sapoviruses (Caliciviruses)
    177 Astroviruses and Picobirnaviruses
    178 Hepatitis E Virus
    B PRION DISEASES
    179 Prions and Prion Disease of the Central Nervous System (Transmissible Neurodegenerative Diseases)
    C CHLAMYDIAL DISEASES
    180 Chlamydia trachomatis (Trachoma and Urogenital Infections)
    181 Psittacosis (Due to Chlamydia psittaci)
    182 Chlamydia pneumoniae
    D MYCOPLASMA DISEASES
    183 Mycoplasma pneumoniae and Atypical Pneumonia
    184 Genital Mycoplasmas: Mycoplasma genitalium, Mycoplasma hominis, and Ureaplasma Species
    E RICKETTSIOSES, EHRLICHIOSES, AND ANAPLASMOSES
    185 Introduction to Rickettsioses, Ehrlichioses, and Anaplasmoses
    186 Rickettsia rickettsii and Other Spotted Fever Group Rickettsiae (Rocky Mountain Spotted Fever and Other Spotted Fevers)
    187 Rickettsia akari (Rickettsialpox)
    188 Coxiella burnetii (Q Fever)
    189 Rickettsia prowazekii (Epidemic or Louse-Borne Typhus)
    190 Rickettsia typhi (Murine Typhus)
    191 Orientia tsutsugamushi (Scrub Typhus)
    192 Ehrlichia chaffeensis (Human Monocytotropic Ehrlichiosis), Anaplasma phagocytophilum (Human Granulocytotropic Anaplasmosis), and Other Anaplasmataceae
    F BACTERIAL DISEASES
    193 Introduction to Bacteria and Bacterial Diseases
    194 Staphylococcus aureus (Including Staphylococcal Toxic Shock Syndrome)
    195 Staphylococcus epidermidis and Other Coagulase-Negative Staphylococci
    196 Classification of Streptococci
    197 Streptococcus pyogenes
    198 Nonsuppurative Poststreptococcal Sequelae: Rheumatic Fever and Glomerulonephritis
    199 Streptococcus pneumoniae
    200 Enterococcus Species, Streptococcus gallolyticus Group, and Leuconostoc Species
    201 Streptococcus agalactiae (Group B Streptococci)
    202 Viridans Streptococci, Nutritionally Variant Streptococci, and Groups C and G Streptococci
    203 Streptococcus anginosus Group
    204 Corynebacterium diphtheriae (Diphtheria)
    205 Other Coryneform Bacteria, Arcanobacterium haemolyticum, and Rhodococci
    206 Listeria monocytogenes
    207 Bacillus anthracis (Anthrax)
    208 Bacillus Species and Related Genera Other Than Bacillus anthracis
    209 Erysipelothrix Rhusiopathiae
    210 Whipple Disease
    211 Neisseria meningitidis
    212 Neisseria gonorrhoeae (Gonorrhea)
    213 Moraxella catarrhalis, Kingella, and Other Gram-Negative Cocci
    214 Vibrio cholerae
    215 Other Pathogenic Vibrios
    216 Campylobacter jejuni and Related Species
    217 Helicobacter pylori and Other Gastric Helicobacter Species
    218 Enterobacteriaceae
    219 Pseudomonas aeruginosa and Other Pseudomonas Species
    220 Stenotrophomonas maltophilia and Burkholderia cepacia Complex
    221 Burkholderia pseudomallei and Burkholderia mallei: Melioidosis and Glanders
    222 Acinetobacter Species
    223 Salmonella Species
    224 Bacillary Dysentery: Shigella and Enteroinvasive Escherichia coli
    225 Haemophilus Species, Including H. influenzae and H. ducreyi (Chancroid)
    226 Brucellosis (Brucella Species)
    227 Francisella tularensis (Tularemia)
    228 Pasteurella Species
    229A Plague (Yersinia pestis)
    229B Yersinia enterocolitica and Yersinia pseudotuberculosis
    230 Bordetella pertussis
    231 Rat-Bite Fever: Streptobacillus moniliformis and Spirillum minus
    232 Legionnaires’ Disease and Pontiac Fever
    233 Capnocytophaga
    234 Bartonella, Including Cat-Scratch Disease
    235 Klebsiella granulomatis (Donovanosis, Granuloma Inguinale)
    236 Other Gram-Negative and Gram-Variable Bacilli
    237 Syphilis (Treponema pallidum)
    238 Endemic Treponematoses
    239 Leptospira Species (Leptospirosis)
    240 Relapsing Fever Caused by Borrelia Species
    241 Lyme Disease (Lyme Borreliosis) Due to Borrelia burgdorferi
    242 Anaerobic Infections: General Concepts
    243 Clostridioides difficile (Formerly Clostridium difficile) Infection
    244 Tetanus (Clostridium tetani)
    245 Botulism (Clostridium botulinum)
    246 Diseases Caused by Clostridium
    247 Bacteroides, Prevotella, Porphyromonas, and Fusobacterium Species (and Other Medically Important Anaerobic Gram-Negative Bacilli)
    248 Anaerobic Cocci and Anaerobic Gram-Positive Nonsporulating Bacilli
    249 Mycobacterium tuberculosis
    250 Leprosy (Mycobacterium leprae)
    251 Mycobacterium avium Complex
    252 Infections Caused by Nontuberculous Mycobacteria Other Than Mycobacterium avium Complex
    253 Nocardia Species
    254 Agents of Actinomycosis
    G MYCOSES
    255 Introduction to Mycoses
    256 Candida Species
    257 Aspergillus Species
    258 Agents of Mucormycosis and Entomophthoramycosis
    259 Sporothrix schenckii
    260 Agents of Chromoblastomycosis
    261 Agents of Mycetoma
    262 Cryptococcosis (Cryptococcus neoformans and Cryptococcus gattii)
    263 Histoplasma capsulatum (Histoplasmosis)
    264 Blastomycosis
    265 Coccidioidomycosis (Coccidioides Species)
    266 Dermatophytosis (Ringworm) and Other Superficial Mycoses
    267 Paracoccidioidomycosis
    268 Uncommon Fungi and Related Species
    269 Pneumocystis Species
    270 Microsporidiosis
    H PROTOZOAL DISEASES
    271 Introduction to Protozoal Diseases
    272 Entamoeba Species, Including Amebic Colitis and Liver Abscess
    273 Free-Living Amebae
    274 Malaria (Plasmodium Species)
    275 Leishmania Species: Visceral (Kala-Azar), Cutaneous, and Mucosal Leishmaniasis
    276 Trypanosoma Species (American Trypanosomiasis, Chagas Disease): Biology of Trypanosomes
    277 Agents of African Trypanosomiasis (Sleeping Sickness)
    278 Toxoplasma gondii
    279 Giardia lamblia
    280 Trichomonas vaginalis
    281 Babesia Species
    282 Cryptosporidiosis (Cryptosporidium Species)
    283 Cyclospora cayetanensis, Cystoisospora belli, Sarcocystis Species, Balantidium coli, and Blastocystis Species
    I DISEASES DUE TO TOXIC ALGAE
    284 Human Illness Associated With Harmful Algal Blooms
    J DISEASES DUE TO HELMINTHS
    285 Introduction to Helminth Infections
    286 Intestinal Nematodes (Roundworms)
    287 Tissue Nematodes, Including Trichinellosis, Dracunculiasis, Filariasis, Loiasis, and Onchocerciasis
    288 Trematodes (Schistosomes and Liver, Intestinal, and Lung Flukes)
    289 Tapeworms (Cestodes)
    290 Visceral Larva Migrans and Other Uncommon Helminth Infections
    K ECTOPARASITIC DISEASES
    291 Introduction to Ectoparasitic Diseases
    292 Lice (Pediculosis)
    293 Scabies
    294 Myiasis and Tungiasis
    295 Mites, Including Chiggers
    296 Ticks, Including Tick Paralysis
    L DISEASES OF UNKNOWN ETIOLOGY
    297 Kawasaki Disease
    IV Special Problems
    A NOSOCOMIAL INFECTIONS
    298 Infection Prevention and Control in the Health Care Setting
    299 Disinfection, Sterilization, and Control of Hospital Waste
    300 Infections Caused by Percutaneous Intravascular Devices
    301 Nosocomial Pneumonia
    302 Health Care-Associated Urinary Tract Infections
    303 Health Care-Acquired Hepatitis
    304 Transfusion- and Transplantation-Transmitted Infections
    B INFECTIONS IN SPECIAL HOSTS
    305 Infections in the Immunocompromised Host: General Principles
    306 Prophylaxis and Empirical Therapy of Infection in Cancer Patients
    307 Infections in Recipients of Hematopoietic Stem Cell Transplants
    308 Infections in Solid-Organ Transplant Recipients
    309 Infections in Patients With Spinal Cord Injury
    310 nfections in Older Adults
    311 Infections in Asplenic Patients
    312 Infections in Injection Drug Users
    313 Surgical Site Infections and Antimicrobial Prophylaxis
    C SURGICAL- AND TRAUMA-RELATED INFECTIONS
    314 Burns
    315 Bites
    D IMMUNIZATION
    316 Immunization
    E ZOONOSES
    317 Zoonoses
    F PROTECTION OF TRAVELERS
    318 Protection of Travelers
    319 Infections in Returning Travelers

  • 2330.00 lei

     

    This second edition of Salem Health: Infectious Diseases & Conditions presents essays on a variety of topics in infectious, or communicable, diseases. Original articles have been updated and new articles added to bring the content up to date.

     

    Scope & Coverage


    This A-Z encyclopedia arranges 632 essays covering all aspects of infectious diseases. This title surveys infectious disease from a variety of perspectives, offering historical and technical (disease-specific) background with a balanced discussion of discoveries, developments, and prognoses. Essays on specific diseases and conditions constitute the core coverage and range from discussions of the common, such as acne and influenza, to the rare, such as prion diseases and necrotizing fasciitis, or flesh-eating bacteria. 

    The set also includes essays reflecting the global reach of infectious disease, exploring topics such as emerging and reemerging infectious diseases, developing countries, epidemics and pandemics, endemic diseases, tropical medicine, globalization, neglected tropical diseases, water quality and treatment, sanitation, and travel. Prominent in the set is discussion of the work of the World Health Organization and other such global health agencies.

    Organization & Format


    Essays vary in length from one to five pages. Every essay begins with ready-reference top matter:

    • Category - lists the focus of the essay (Diagnosis, Diseases and conditions, Epidemiology, Immune response, Pathogen, Prevention, Transmission, and Treatment;
    • Also Known As - provides alternative names used;
    • Transmission Route - is listed for pathogen essays;
    • Anatomy or System Affected - lists areas of the body affected for diseases and conditions essays;
    • Definition - introduces, defines, and describes essay topic;

    Essays on disease and conditions provide information in the following text subsections:

    • Causes
    • Risk Factors
    • Symptoms
    • Screening and Diagnosis
    • Treatment and Therapy
    • Prevention and Outcomes

    Pathogen essays include Natural Habitat and Features as well as a sidebar providing the pathogen's taxonomic classification, listing information on genus and species, among other ranks.

    Topical Subheads and explanation of Impact are included in essays covering diagnosis, epidemiology, immune response, prevention, and treatment. All essays conclude with Contributor Byline, Further Reading, Web Sites of Interest, and See Also.

    Special Features

    • Key Terms and Facts
    • Newsworthy Topics
    • Questions to Ask One's Health Care Provider
    • Tables and Statistical Data
    • Photographs, Charts and other Media

    Reference Tools (glossary, bibliography, resources, web sites, medical journals, pharmaceutical list) and Historical Resources (timeline of major developments in infectious disease, biographical dictionary of scientists in infectious disease, Nobel Prize for discoveries in infectious disease) finalize Volume 3, as well as three indexes for subject, category, and entries by anatomy or system affected.

    The essays were written for non-specialists by medical professionals such as doctors, nurses, clinical practitioners, researchers, and therapists, as well as professors in science and medicine and professional medical writersSalem Health: Infectious Diseases & Conditions will interest science and premedical students, students of epidemiology and public health, students of global and tropical medicine, public library patrons, and librarians building collections in science and medicine.

    Complete List of Contents

     

    Volume 1

    Contents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . v

    Publisher’s Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . ix

    Editor’s Introduction to the First Edition . . . . . . xiii

    Editor’s Introduction to the Second Edition . . . . xv

    Contributors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xvii

    Abscesses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

    Acanthamoeba and other

    free-living infections . . . . . . . . . . . . . . . . . . . . . . 3

    Acariasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5

    Acne . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7

    Actinomycosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9

    Acute cerebellar ataxia . . . . . . . . . . . . . . . . . . . . . 10

    Acute cystitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11

    Acute interstitial nephritis . . . . . . . . . . . . . . . . . . . 13

    Acute necrotizing ulcerative gingivitis . . . . . . . . . 14

    Adenoviridae . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15

    Adenovirus infections . . . . . . . . . . . . . . . . . . . . . . 16

    Adenovirus vaccine . . . . . . . . . . . . . . . . . . . . . . . . 17

    African sleeping sickness . . . . . . . . . . . . . . . . . . . . 19

    Agammaglobulinemia . . . . . . . . . . . . . . . . . . . . . . 20

    Aging and infectious disease . . . . . . . . . . . . . . . . . 22

    AIDS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26

    Airborne illness and disease . . . . . . . . . . . . . . . . . 30

    Allergic bronchopulmonary aspergillosis . . . . . . 34

    Alliance for the Prudent Use of Antibiotics . . . . . 35

    Alternative therapies for infectious diseases . . . . 36

    Amebic dysentery . . . . . . . . . . . . . . . . . . . . . . . . . . 40

    Aminoglycoside antibiotics . . . . . . . . . . . . . . . . . . 42

    Anal abscess . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44

    Anaplasmosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45

    Anthrax . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46

    Anthrax vaccine . . . . . . . . . . . . . . . . . . . . . . . . . . . 48

    Antibiotic resistance . . . . . . . . . . . . . . . . . . . . . . . . 49

    Antibiotic stewardship . . . . . . . . . . . . . . . . . . . . . . 52

    Antibiotics: Types . . . . . . . . . . . . . . . . . . . . . . . . . . 53

    Antibodies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56

    Antifungal drugs: Types . . . . . . . . . . . . . . . . . . . . . 58

    Antifungal drugs: Mechanisms of action . . . . . . . 60

    Antiparasitic drugs: Types . . . . . . . . . . . . . . . . . . . 62

    Antiparasitic drugs: Mechanisms of action . . . . . 64

    Antiviral drugs: Types . . . . . . . . . . . . . . . . . . . . . . 68

    Antiviral drugs: Mechanisms of action . . . . . . . . . 70

    Appendicitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72

    Arenaviridae . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73

    Arthropod-borne illness and disease . . . . . . . . . . 75

    Ascariasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79

    Aseptic technique . . . . . . . . . . . . . . . . . . . . . . . . . 80

    Aspergillosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82

    Aspergillus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84

    Asplenia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86

    Athlete’s foot . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88

    Atypical pneumonia . . . . . . . . . . . . . . . . . . . . . . . . 89

    Autoimmune disorders . . . . . . . . . . . . . . . . . . . . . 91

    Avian influenza............................. 95

    Babesiosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98

    Bacteria classifications and types . . . . . . . . . . . . . 99

    Bacteria: Structure and growth . . . . . . . . . . . . . . 103

    Bacterial endocarditis . . . . . . . . . . . . . . . . . . . . . 106

    Bacterial infections . . . . . . . . . . . . . . . . . . . . . . . 108

    Bacterial meningitis . . . . . . . . . . . . . . . . . . . . . . . 112

    Bacterial vaginosis . . . . . . . . . . . . . . . . . . . . . . . . 114

    Bacteriology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116

    Balantidiasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118

    Bartonella infections . . . . . . . . . . . . . . . . . . . . . . . 119

    Bats and infectious disease . . . . . . . . . . . . . . . . . 121

    Behçet’s syndrome . . . . . . . . . . . . . . . . . . . . . . . . 122

    Bell’s palsy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124

    Biochemical tests . . . . . . . . . . . . . . . . . . . . . . . . . 125

    Biological weapons......................... 127

    Biostatistics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131

    Biosurveillance . . . . . . . . . . . . . . . . . . . . . . . . . . . 132

    Bioterrorism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136

    Birds and infectious disease . . . . . . . . . . . . . . . . 139

    BK virus infection . . . . . . . . . . . . . . . . . . . . . . . . 142

    Blastomyces . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143

    Blastomycosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 145

    Blood-borne illness and disease . . . . . . . . . . . . . 146

    Bloodstream infections . . . . . . . . . . . . . . . . . . . . 150

    Body lice . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152

    Boils . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 153

    Bordetella . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 154

    Borrelia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 156

    Bot Fly . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 158

    Botulinum toxin infection . . . . . . . . . . . . . . . . . . 159

    Botulism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161

    Breast milk and infectious disease . . . . . . . . . . . 163

    Bronchiolitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164

    Salem Health: Infectious Diseases and Conditions

    Bronchitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 166

    Brucella . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 168

    Brucellosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 169

    Brucellosis vaccine . . . . . . . . . . . . . . . . . . . . . . . . 171

    Bubonic plague . . . . . . . . . . . . . . . . . . . . . . . . . . 172

    Bubonic plague vaccine . . . . . . . . . . . . . . . . . . . . 176

    Burkholderia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 177

    Caliciviridae . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 180

    Campylobacter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 181

    Campylobacteriosis . . . . . . . . . . . . . . . . . . . . . . . 182

    Cancer and infectious disease . . . . . . . . . . . . . . . 184

    Cancer vaccines . . . . . . . . . . . . . . . . . . . . . . . . . . 188

    Candida . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 190

    Candida auris . . . . . . . . . . . . . . . . . . . . . . . . . . . . 194

    Candidiasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 195

    Capillariasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 197

    Capnocytophaga infections . . . . . . . . . . . . . . . . . . 198

    Carbapenem-resistant Enterobacteriaceae (CRE) . 200

    Carriers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 202

    Cat scratch disease (CSD) . . . . . . . . . . . . . . . . . . 203

    Cats and infectious disease . . . . . . . . . . . . . . . . . 204

    Causes and management of epidemics and

    pandemics . . . . . . . . . . . . . . . . . . . . . . . . . . . . 207

    Cellulitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 210

    Centers for Disease Control and Prevention

    (CDC) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 211

    Cephalosporin antibiotics . . . . . . . . . . . . . . . . . . 215

    Cervical cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . 217

    Chagas’ disease . . . . . . . . . . . . . . . . . . . . . . . . . . . 221

    Chancroid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 223

    Chemical germicides . . . . . . . . . . . . . . . . . . . . . . 224

    Chickenpox . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 226

    Chickenpox vaccine . . . . . . . . . . . . . . . . . . . . . . . 230

    Chikungunya . . . . . . . . . . . . . . . . . . . . . . . . . . . . 231

    Childbirth and infectious disease . . . . . . . . . . . . 232

    Children and infectious disease . . . . . . . . . . . . . 236

    Chlamydia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 241

    Chlamydophila . . . . . . . . . . . . . . . . . . . . . . . . . . . . 243

    Chlamydophila pneumoniae infection . . . . . . . . . . 245

    Cholecystitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 246

    Cholera . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 248

    Cholera vaccine . . . . . . . . . . . . . . . . . . . . . . . . . . 251

    Chromoblastomycosis . . . . . . . . . . . . . . . . . . . . . 252

    Chronic fatigue syndrome . . . . . . . . . . . . . . . . . . 253

    Clonorchiasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 257

    Clonorchis sinesis . . . . . . . . . . . . . . . . . . . . . . . . . . 258

    Clostridium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 259

    Clostridium difficile infection . . . . . . . . . . . . . . . . . 261

    Coccidioides . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 264

    Coccidiosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 265

    Cold sores . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 267

    Colorado tick fever (CTF) . . . . . . . . . . . . . . . . . . 269

    Common cold . . . . . . . . . . . . . . . . . . . . . . . . . . . 271

    Conjunctivitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 272

    Contagious diseases . . . . . . . . . . . . . . . . . . . . . . . 274

    Coronaviridae . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 278

    Coronavirus infections . . . . . . . . . . . . . . . . . . . . 279

    Corynebacterium . . . . . . . . . . . . . . . . . . . . . . . . . . . 280

    Cowpox . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 282

    Coxsackie virus infections . . . . . . . . . . . . . . . . . . 283

    Crab lice . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 284

    Creutzfeldt-Jakob disease . . . . . . . . . . . . . . . . . . . 286

    Croup . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 288

    Cryptococcosis . . . . . . . . . . . . . . . . . . . . . . . . . . . 290

    Cryptococcus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 291

    Cryptosporidiosis . . . . . . . . . . . . . . . . . . . . . . . . . 293

    Cyclospora infection . . . . . . . . . . . . . . . . . . . . . . . . 295

    Cystic Fibrosis Respiratory Infections . . . . . . . . . 297

    Cysticercosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 299

    Cytomegalovirus infection . . . . . . . . . . . . . . . . . . 301

    Cytomegalovirus vaccine . . . . . . . . . . . . . . . . . . . 302

    Dacryocystitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 304

    Dandruff . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 305

    DDT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 306

    Decontamination . . . . . . . . . . . . . . . . . . . . . . . . . 307

    Dengue fever . . . . . . . . . . . . . . . . . . . . . . . . . . . . 308

    Dermatomycosis . . . . . . . . . . . . . . . . . . . . . . . . . . 310

    Dermatophytosis . . . . . . . . . . . . . . . . . . . . . . . . . 311

    Developing countries and infectious disease . . . 313

    Diagnosis of bacterial infections . . . . . . . . . . . . . 316

    Diagnosis of fungal infections . . . . . . . . . . . . . . . 319

    Diagnosis of parasitic diseases . . . . . . . . . . . . . . . 321

    Diagnosis of prion diseases . . . . . . . . . . . . . . . . . 322

    Diagnosis of protozoan diseases . . . . . . . . . . . . . 324

    Diagnosis of viral infections . . . . . . . . . . . . . . . . 326

    Diphtheria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 328

    Disease eradication campaigns . . . . . . . . . . . . . . 329

    Disinfectants and sanitizers . . . . . . . . . . . . . . . . . 331

    Disseminated intravascular coagulation . . . . . . 333

    Disseminated intravascular coagulopathy (DIC). 335

    Diverticulitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 337

    Dogs and infectious disease . . . . . . . . . . . . . . . . . 339

    Dracunculiasis . . . . . . . . . . . . . . . . . . . . . . . . . . . 342

    Drug resistance . . . . . . . . . . . . . . . . . . . . . . . . . . 343

    DTaP vaccine . . . . . . . . . . . . . . . . . . . . . . . . . . . . 347

    Duodenal ulcer . . . . . . . . . . . . . . . . . . . . . . . . . . 348

    Eastern equine encephalitis . . . . . . . . . . . . . . . . 350

    Ebola hemorrhagic fever . . . . . . . . . . . . . . . . . . . 351

    Echinocandin antifungals . . . . . . . . . . . . . . . . . . 353

    Echinococcus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 355

    Complete List of Contents

    Echovirus infections . . . . . . . . . . . . . . . . . . . . . . 356

    Ehrlichiosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 357

    Eikenella infections . . . . . . . . . . . . . . . . . . . . . . . . . 358

    Elephantiasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 359

    Emerging and reemerging infectious diseases . 361

    Emerging Infections Network (EIN) . . . . . . . . . 365

    Empyema . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 366

    Encephalitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 368

    Encephalitis vaccine . . . . . . . . . . . . . . . . . . . . . . . 369

    Endemic infections . . . . . . . . . . . . . . . . . . . . . . . 370

    Endocarditis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 372

    Endometritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 374

    Enteritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 375

    Enterobacter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 377

    Enterobiasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 379

    Enterococcus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 380

    Enterovirus infections . . . . . . . . . . . . . . . . . . . . . 382

    Epidemic Intelligence Service (EIS) . . . . . . . . . 384

    Epidemics and pandemics: Causes and

    management . . . . . . . . . . . . . . . . . . . . . . . . . . 386

    Epidemics and pandemics: History . . . . . . . . . . 390

    Epidemiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . 394

    Epidermophyton . . . . . . . . . . . . . . . . . . . . . . . . . . . 398

    Epididymitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 399

    Epiglottitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 401

    Epstein-Barr virus infection.................. 403

    Epstein-Barr virus vaccine . . . . . . . . . . . . . . . . . . 405

    Erysipelas . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 406

    Erysipelothrix infection . . . . . . . . . . . . . . . . . . . . . 407

    Erythema infectiosum . . . . . . . . . . . . . . . . . . . . . 408

    Erythema nodosum . . . . . . . . . . . . . . . . . . . . . . . 409

    Escherichia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 411

    Escherichia coli infection . . . . . . . . . . . . . . . . . . . . 412

    Eye infections . . . . . . . . . . . . . . . . . . . . . . . . . . . . 415

    Volume 2

    Contents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . v

    Complete List of Contents . . . . . . . . . . . . . . . . . . . ix

    Fasciitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 419

    Fatal familial insomnia . . . . . . . . . . . . . . . . . . . . 420

    Fecal-oral route of transmission . . . . . . . . . . . . . 421

    Fever . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 423

    Fever of unknown origin . . . . . . . . . . . . . . . . . . . 424

    Filariasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 426

    Filoviridae . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 427

    Fleas and infectious disease . . . . . . . . . . . . . . . . . 429

    Flies and infectious disease . . . . . . . . . . . . . . . . . 431

    Flukes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 433

    Food-borne illness and disease . . . . . . . . . . . . . . 435

    Francisella . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 439

    Fungi classification and types . . . . . . . . . . . . . . . 441

    Fungi: Structure and growth . . . . . . . . . . . . . . . . 446

    Fusarium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 450

    Gangrene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 453

    Gastritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 454

    Genital herpes . . . . . . . . . . . . . . . . . . . . . . . . . . . 455

    Genital warts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 458

    Gerstmann-Sträussler-Scheinker syndrome

    (GSS) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 460

    Giardia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 462

    Giardiasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 463

    Gingivitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 465

    Glanders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 467

    Global Warming and Infectious Diseases . . . . . . 468

    Globalization and infectious disease........... 470

    Glycopeptide antibiotics . . . . . . . . . . . . . . . . . . . 475

    Gonorrhea . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 476

    Graft-versus-host disease (GVHD) . . . . . . . . . . . 479

    Gram staining . . . . . . . . . . . . . . . . . . . . . . . . . . . . 481

    Group A streptococcal infection . . . . . . . . . . . . . 483

    Group B streptococcal infection . . . . . . . . . . . . . 484

    Guillain-Barré syndrome . . . . . . . . . . . . . . . . . . . 486

    Haemophilus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 489

    Haemophilus influenzae infection . . . . . . . . . . . . . 490

    Hand, foot, and mouth disease . . . . . . . . . . . . . . 492

    Hantavirus infection . . . . . . . . . . . . . . . . . . . . . . 493

    Head lice................................. 495

    Helicobacter................................ 496

    Helicobacter pylori infection . . . . . . . . . . . . . . . . . . 498

    Hemolytic uremic syndrome . . . . . . . . . . . . . . . . 499

    Hemorrhagic fever viral infections . . . . . . . . . . . 501

    Hepadnaviridiae . . . . . . . . . . . . . . . . . . . . . . . . . . 505

    Hepatitis A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 507

    Hepatitis B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 508

    Hepatitis C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 510

    Hepatitis D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 513

    Hepatitis E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 514

    Hepatitis vaccines . . . . . . . . . . . . . . . . . . . . . . . . . 515

    Herpes simplex infection . . . . . . . . . . . . . . . . . . 516

    Herpes zoster infection . . . . . . . . . . . . . . . . . . . . 517

    Herpes zoster vaccines . . . . . . . . . . . . . . . . . . . . . 519

    Herpesviridae . . . . . . . . . . . . . . . . . . . . . . . . . . . . 520

    Herpesvirus infections . . . . . . . . . . . . . . . . . . . . . 522

    Salem Health: Infectious Diseases and Conditions

    Hib vaccine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 524

    Histoplasma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 525

    Histoplasmosis . . . . . . . . . . . . . . . . . . . . . . . . . . . 527

    HIV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 528

    HIV vaccine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 532

    Home remedies for infectious diseases . . . . . . . 533

    Hookworms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 535

    Hordeola . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 536

    Horizontal disease transmission . . . . . . . . . . . . . 538

    Hospitals and infectious disease . . . . . . . . . . . . . 539

    Hosts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 543

    Human papillomavirus (HPV) infections . . . . . 544

    Human papillomavirus (HPV) vaccine . . . . . . . 546

    Hygiene.................................. 548

    Hyperbaric oxygen . . . . . . . . . . . . . . . . . . . . . . . . 549

    Iatrogenic infections . . . . . . . . . . . . . . . . . . . . . . 551

    Idiopathic thrombocytopenic purpura . . . . . . . 553

    Imidazole antifungals . . . . . . . . . . . . . . . . . . . . . 555

    Immune response to bacterial infections . . . . . . 556

    Immune response to fungal infections . . . . . . . . 558

    Immune response to parasitic diseases . . . . . . . . 560

    Immune response to prion diseases . . . . . . . . . . 562

    Immune response to protozoan diseases . . . . . . 563

    Immune response to viral infections . . . . . . . . . 565

    Immunity and infectious disease.............. 567

    Immunization and infectious disease . . . . . . . . . 569

    Immunoassay . . . . . . . . . . . . . . . . . . . . . . . . . . . . 574

    Immunodeficiency . . . . . . . . . . . . . . . . . . . . . . . . 577

    Impetigo . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 578

    Incubation period . . . . . . . . . . . . . . . . . . . . . . . . 580

    Infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 581

    Infectious disease specialists . . . . . . . . . . . . . . . . 583

    Infectious Diseases Society of America . . . . . . . . 585

    Inflammation . . . . . . . . . . . . . . . . . . . . . . . . . . . . 587

    Influenza................................. 590

    Influenza vaccine . . . . . . . . . . . . . . . . . . . . . . . . . 593

    Insect-borne illness and disease . . . . . . . . . . . . . 595

    Insecticides and topical repellants . . . . . . . . . . . 599

    Integrase inhibitors . . . . . . . . . . . . . . . . . . . . . . . 601

    Intestinal and stomach infections . . . . . . . . . . . . 602

    Intestinal trichomoniasis . . . . . . . . . . . . . . . . . . . 606

    Isosporiasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 608

    Japanese encephalitis . . . . . . . . . . . . . . . . . . . . . . 610

    Jock itch . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 611

    Kaposi’s sarcoma . . . . . . . . . . . . . . . . . . . . . . . . . 614

    Kawasaki disease . . . . . . . . . . . . . . . . . . . . . . . . . . 615

    Keratitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 616

    Ketolide antibiotics . . . . . . . . . . . . . . . . . . . . . . . 618

    Kidney infection . . . . . . . . . . . . . . . . . . . . . . . . . . 619

    Koch’s postulates . . . . . . . . . . . . . . . . . . . . . . . . . 621

    Kuru . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 622

    Labyrinthitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 624

    Laryngitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 625

    Lassa fever . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 627

    Legionella . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 628

    Legionnaires’ disease . . . . . . . . . . . . . . . . . . . . . . 629

    Leishmaniasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 631

    Leprosy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 633

    Leptospira . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 635

    Leptospirosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 636

    Lipopeptide antibiotics . . . . . . . . . . . . . . . . . . . . 638

    Listeria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 639

    Listeriosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 640

    Liver cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 642

    Lyme disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . 644

    Lymphadenitis . . . . . . . . . . . . . . . . . . . . . . . . . . . 648

    Macrolide antibiotics . . . . . . . . . . . . . . . . . . . . . . 650

    Malaria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 651

    Malaria vaccine . . . . . . . . . . . . . . . . . . . . . . . . . . . 653

    Malassezia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 654

    Marburg hemorrhagic fever . . . . . . . . . . . . . . . . 656

    MALDI-TOF Mass Spectrometry . . . . . . . . . . . . . 657

    Mastitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 659

    Mathematical modeling and infectious diseases. 661

    Maturation inhibitors . . . . . . . . . . . . . . . . . . . . . 663

    Measles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 664

    Mediterranean spotted fever . . . . . . . . . . . . . . . . 666

    Melioidosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 667

    Men and infectious disease . . . . . . . . . . . . . . . . . 669

    Meningococcal meningitis . . . . . . . . . . . . . . . . . 671

    Meningococcal vaccine . . . . . . . . . . . . . . . . . . . . 673

    Metapneumovirus infection . . . . . . . . . . . . . . . . 674

    Methicillin-resistant staph infection . . . . . . . . . . 675

    Microbiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . 677

    Microbiome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 679

    Microscopy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 681

    Microsporum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 683

    Middle-ear infection . . . . . . . . . . . . . . . . . . . . . . 684

    Mites and chiggers and infectious disease . . . . . 687

    MMR vaccine . . . . . . . . . . . . . . . . . . . . . . . . . . . . 690

    Molecular Microbiology . . . . . . . . . . . . . . . . . . . 691

    Molluscum contagiosum . . . . . . . . . . . . . . . . . . . 693

    Monkey B virus . . . . . . . . . . . . . . . . . . . . . . . . . . . 695

    Monkeypox . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 696

    Mononucleosis . . . . . . . . . . . . . . . . . . . . . . . . . . . 698

    Mosquito-borne viral encephalitis . . . . . . . . . . . 700

    Mosquitoes and infectious disease . . . . . . . . . . . 701

    Mouth infections . . . . . . . . . . . . . . . . . . . . . . . . . 704

    Complete List of Contents

    Mucormycosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 708

    Multi-Drug Resistance . . . . . . . . . . . . . . . . . . . . . 709

    Mumps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 712

    Mutation of pathogens . . . . . . . . . . . . . . . . . . . . 714

    Mycetoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 717

    Mycobacterial infections . . . . . . . . . . . . . . . . . . . 718

    Mycobacterium . . . . . . . . . . . . . . . . . . . . . . . . . . . . 720

    Mycoplasma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 722

    Mycoplasma pneumonia . . . . . . . . . . . . . . . . . . . . . 723

    Mycoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 725

    Mycotic aneurysm . . . . . . . . . . . . . . . . . . . . . . . . 726

    Myocarditis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 727

    Myositis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 729

    Nasopharyngeal infections . . . . . . . . . . . . . . . . . 731

    National Institute of Allergy and Infectious

    Diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 733

    National Institutes of Health . . . . . . . . . . . . . . . . 734

    Necrotizing fasciitis . . . . . . . . . . . . . . . . . . . . . . . 736

    Neisseria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 738

    Neisserial infections . . . . . . . . . . . . . . . . . . . . . . . 740

    Neonatal sepsis . . . . . . . . . . . . . . . . . . . . . . . . . . . 741

    Neutropenia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 743

    Nocardiosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 744

    Norovirus infection . . . . . . . . . . . . . . . . . . . . . . . 745

    Onchocerciasis . . . . . . . . . . . . . . . . . . . . . . . . . . . 748

    Onychomycosis............................ 750

    Ophthalmia neonatorum . . . . . . . . . . . . . . . . . . 751

    Opportunistic infections . . . . . . . . . . . . . . . . . . . 753

    Oral transmission . . . . . . . . . . . . . . . . . . . . . . . . . 755

    Ornithosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 757

    Osteomyelitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 758

    Outbreaks of infectious disease . . . . . . . . . . . . . . 759

    Over-the-counter (OTC) drugs and infectious

    disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 761

    Oxazolidinone antibiotics . . . . . . . . . . . . . . . . . . 764

    Pacemaker infections . . . . . . . . . . . . . . . . . . . . . . 766

    Pancreatitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 768

    Paracoccidiodes . . . . . . . . . . . . . . . . . . . . . . . . . . . . 769

    Paracoccidioidomycosis . . . . . . . . . . . . . . . . . . . . 771

    Paramyxoviridae . . . . . . . . . . . . . . . . . . . . . . . . . . 772

    Parasite classification and types . . . . . . . . . . . . . 774

    Parasitic diseases . . . . . . . . . . . . . . . . . . . . . . . . . 777

    Parasitology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 779

    Parechovirus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 782

    Parotitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 783

    Parvoviridae . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 785

    Parvovirus infections . . . . . . . . . . . . . . . . . . . . . . 786

    Pasteurellosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 788

    Pathogenicity . . . . . . . . . . . . . . . . . . . . . . . . . . . . 790

    Pathogens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 791

    Pelvic inflammatory disease . . . . . . . . . . . . . . . . 795

    Penicillin allergy testing . . . . . . . . . . . . . . . . . . . 797

    Penicillin antibiotics . . . . . . . . . . . . . . . . . . . . . . 799

    Penicilliosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 801

    Peptic ulcer............................... 802

    Pericarditis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 806

    Peritonitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 807

    Pharyngitis and tonsillopharyngitis . . . . . . . . . . 808

    Picornaviridae . . . . . . . . . . . . . . . . . . . . . . . . . . . 810

    Picornavirus infections . . . . . . . . . . . . . . . . . . . . 811

    Piedraia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 813

    Pigs and infectious disease . . . . . . . . . . . . . . . . . 814

    Pilonidal cyst . . . . . . . . . . . . . . . . . . . . . . . . . . . . 816

    Pinta . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 817

    Pinworms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 818

    Pityriasis rosea . . . . . . . . . . . . . . . . . . . . . . . . . . . 820

    Plague . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 821

    Plantar warts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 823

    Pleurisy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 824

    Pneumococcal infections.................... 826

    Pneumococcal vaccine . . . . . . . . . . . . . . . . . . . . . 827

    Pneumocystis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 830

    Pneumocystis pneumonia . . . . . . . . . . . . . . . . . . 831

    Pneumonia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 833

    Polio vaccine.............................. 835

    Poliomyelitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 836

    Polyene antifungals . . . . . . . . . . . . . . . . . . . . . . . 838

    Polymerase chain reaction (PCR) method . . . . 839

    Pontiac fever . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 841

    Postherpetic neuralgia . . . . . . . . . . . . . . . . . . . . . 843

    Powassan virus . . . . . . . . . . . . . . . . . . . . . . . . . . . 844

    Poxviridae................................. 845

    Poxvirus infections . . . . . . . . . . . . . . . . . . . . . . . . 847

    Pregnancy and infectious disease . . . . . . . . . . . . 848

    Prevention of bacterial infections . . . . . . . . . . . . 853

    Prevention of fungal infections . . . . . . . . . . . . . . 854

    Prevention of parasitic diseases . . . . . . . . . . . . . . 856

    Prevention of protozoan diseases . . . . . . . . . . . . 858

    Prevention of viral infections . . . . . . . . . . . . . . . 859

    Primary infection . . . . . . . . . . . . . . . . . . . . . . . . . 861

    Primates and infectious disease . . . . . . . . . . . . . 863

    Prion diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . . 864

    Prions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 868

    Progressive multifocal leukoencephalopathy . . . 870

    Prostatitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 871

    Prosthetic joint infections . . . . . . . . . . . . . . . . . . 873

    Protease inhibitors . . . . . . . . . . . . . . . . . . . . . . . . 875

    Protozoa classification and types . . . . . . . . . . . . . 877

    Salem Health: Infectious Diseases and Conditions

    Protozoan diseases . . . . . . . . . . . . . . . . . . . . . . . . 878

    Pseudomonas . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 881

    Pseudomonas infections . . . . . . . . . . . . . . . . . . . . . 883

    Psittacosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 884

    Psychological effects of infectious disease . . . . . 885

    Public health . . . . . . . . . . . . . . . . . . . . . . . . . . . . 887

    Puerperal infection . . . . . . . . . . . . . . . . . . . . . . . 892

    Pulsed Field Gel Electrophoresis (PFGE) . . . . . 893

    Volume 3

    Contents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . v

    Complete List of Contents . . . . . . . . . . . . . . . . . . vii

    Q fever . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 897

    Quarantine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 898

    Quinolone antibiotics . . . . . . . . . . . . . . . . . . . . . 899

    Rabies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 901

    Rabies vaccine . . . . . . . . . . . . . . . . . . . . . . . . . . . 903

    Rat-bite fever . . . . . . . . . . . . . . . . . . . . . . . . . . . . 904

    Reinfection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 906

    Reiter’s syndrome . . . . . . . . . . . . . . . . . . . . . . . . 907

    Reoviridae . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 909

    Reptiles and infectious disease . . . . . . . . . . . . . . 911

    Respiratory route of transmission . . . . . . . . . . . . 913

    Respiratory syncytial virus infections . . . . . . . . . 914

    Retroviral infections . . . . . . . . . . . . . . . . . . . . . . . 916

    Retroviridae . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 918

    Reverse transcriptase inhibitors . . . . . . . . . . . . . 920

    Rheumatic fever . . . . . . . . . . . . . . . . . . . . . . . . . . 922

    Rhinosporidiosis . . . . . . . . . . . . . . . . . . . . . . . . . 923

    Rhinovirus infections . . . . . . . . . . . . . . . . . . . . . . 924

    Rhizopus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 925

    Rickettsia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 927

    Rickettsia parkeri infection . . . . . . . . . . . . . . . . . 929

    Rickettsial diseases . . . . . . . . . . . . . . . . . . . . . . . . 931

    Rift Valley fever............................ 933

    Ringworm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 934

    Rocky Mountain Spotted fever . . . . . . . . . . . . . . 935

    Rodents and infectious disease . . . . . . . . . . . . . . 937

    Roseola . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 938

    Rotavirus infection . . . . . . . . . . . . . . . . . . . . . . . . 939

    Rotavirus vaccine . . . . . . . . . . . . . . . . . . . . . . . . . 941

    Rubella . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 942

    Saliva and infectious disease . . . . . . . . . . . . . . . . 945

    Salmonella . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 946

    Salmonellosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 949

    Sarcoidosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 951

    Sarcosporidiosis . . . . . . . . . . . . . . . . . . . . . . . . . . 952

    SARS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 953

    Scabies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 955

    Scarlet fever . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 957

    Schistosomiasis . . . . . . . . . . . . . . . . . . . . . . . . . . . 958

    Schools and infectious disease . . . . . . . . . . . . . . 961

    Secondary infection . . . . . . . . . . . . . . . . . . . . . . . 965

    Sepsis.................................... 966

    Septic arthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . 968

    Septic shock . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 969

    Seroconversion . . . . . . . . . . . . . . . . . . . . . . . . . . . 971

    Serology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 972

    Sexually transmitted diseases (STDs) . . . . . . . . . 974

    Shigella . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 978

    Shigellosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 980

    Shingles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 982

    Sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 984

    Skin infections . . . . . . . . . . . . . . . . . . . . . . . . . . . 987

    Sleeping nets . . . . . . . . . . . . . . . . . . . . . . . . . . . . 989

    Sleeping sickness . . . . . . . . . . . . . . . . . . . . . . . . . 990

    Smallpox . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 991

    Smallpox vaccine . . . . . . . . . . . . . . . . . . . . . . . . . 993

    Social effects of infectious disease . . . . . . . . . . . 994

    Soilborne illness and disease . . . . . . . . . . . . . . . . 998

    Sporotrichosis . . . . . . . . . . . . . . . . . . . . . . . . . . . 1003

    Stachybotrys . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1004

    Staphylococcal infections . . . . . . . . . . . . . . . . . 1006

    Staphylococcus . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1008

    Stenotrophomonas infections . . . . . . . . . . . . . . . . 1010

    Strep throat . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1011

    Streptococcal infections . . . . . . . . . . . . . . . . . . 1012

    Streptococcus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1014

    Stress and infectious disease . . . . . . . . . . . . . . . 1016

    Strongyloidiasis . . . . . . . . . . . . . . . . . . . . . . . . . 1018

    Subacute sclerosing panencephalitis . . . . . . . . 1019

    Syphilis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1020

    T lymphocytes . . . . . . . . . . . . . . . . . . . . . . . . . . 1023

    Taeniasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1024

    Tapeworms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1025

    Tetanus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1027

    Tetracycline antibiotics . . . . . . . . . . . . . . . . . . . 1029

    Thiazole antifungals . . . . . . . . . . . . . . . . . . . . . 1030

    Thrush (infection) . . . . . . . . . . . . . . . . . . . . . . . 1032

    Tick paralysis . . . . . . . . . . . . . . . . . . . . . . . . . . . 1033

    Ticks and infectious disease . . . . . . . . . . . . . . . 1034

    Tinea capitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1037

    Tinea corporis . . . . . . . . . . . . . . . . . . . . . . . . . . 1038

    Complete List of Contents

    Tinea versicolor . . . . . . . . . . . . . . . . . . . . . . . . . 1040

    Tooth abscess . . . . . . . . . . . . . . . . . . . . . . . . . . . 1041

    Toxocariasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1042

    Toxoplasmosis . . . . . . . . . . . . . . . . . . . . . . . . . . 1043

    Trachoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1045

    Transmission routes . . . . . . . . . . . . . . . . . . . . . . 1046

    Transplant infections . . . . . . . . . . . . . . . . . . . . . 1050

    Travel medicine . . . . . . . . . . . . . . . . . . . . . . . . . 1052

    Travel medicine specialists . . . . . . . . . . . . . . . . 1054

    Travelers’ diarrhea . . . . . . . . . . . . . . . . . . . . . . . 1055

    Treatment of bacterial infections . . . . . . . . . . . 1057

    Treatment of fungal infections . . . . . . . . . . . . . 1058

    Treatment of parasitic diseases . . . . . . . . . . . . . 1060

    Treatment of prion diseases . . . . . . . . . . . . . . . 1062

    Treatment of protozoan diseases . . . . . . . . . . . 1064

    Treatment of viral infections . . . . . . . . . . . . . . . 1066

    Treponema . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1067

    Triazole antifungals . . . . . . . . . . . . . . . . . . . . . . 1069

    Trichinosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1070

    Trichomonas . . . . . . . . . . . . . . . . . . . . . . . . . . . 1072

    Trichophyton . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1074

    Tropical medicine . . . . . . . . . . . . . . . . . . . . . . . 1076

    Trypanosoma (genus) . . . . . . . . . . . . . . . . . . . . . 1079

    Trypanosomiasis . . . . . . . . . . . . . . . . . . . . . . . . . 1081

    Trypanosomiasis vaccine . . . . . . . . . . . . . . . . . . 1082

    Tuberculosis (TB) . . . . . . . . . . . . . . . . . . . . . . . 1083

    Tuberculosis (TB) vaccine . . . . . . . . . . . . . . . . . 1086

    Tularemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1087

    Typhoid fever . . . . . . . . . . . . . . . . . . . . . . . . . . . 1089

    Typhoid vaccine . . . . . . . . . . . . . . . . . . . . . . . . . 1090

    Typhus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1092

    Typhus vaccine . . . . . . . . . . . . . . . . . . . . . . . . . . 1094

    U.S. Army Medical Research Institute

    of Infectious Diseases . . . . . . . . . . . . . . . . . . 1096

    Urethritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1098

    Urinary tract infections . . . . . . . . . . . . . . . . . . . 1099

    Vaccine types . . . . . . . . . . . . . . . . . . . . . . . . . . . 1102

    Vaccines: Experimental . . . . . . . . . . . . . . . . . . . 1106

    Vaccines: History . . . . . . . . . . . . . . . . . . . . . . . . 1108

    Vaginal yeast infection . . . . . . . . . . . . . . . . . . . . 1112

    Vancomycin-resistant enterococci infection . . . 1113

    Variant Creutzfeldt-Jakob disease . . . . . . . . . . . 1114

    Vectors and vector control . . . . . . . . . . . . . . . . . 1116

    Vertical disease transmission . . . . . . . . . . . . . . . 1118

    Vibrio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1119

    Vincent’s angina . . . . . . . . . . . . . . . . . . . . . . . . . 1121

    Viral gastroenteritis . . . . . . . . . . . . . . . . . . . . . . 1122

    Viral hepatitis . . . . . . . . . . . . . . . . . . . . . . . . . . . 1123

    Viral infections . . . . . . . . . . . . . . . . . . . . . . . . . . 1125

    Viral meningitis . . . . . . . . . . . . . . . . . . . . . . . . . 1127

    Viral pharyngitis . . . . . . . . . . . . . . . . . . . . . . . . . 1129

    Viral upper respiratory infections . . . . . . . . . . . 1130

    Virology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1133

    Virulence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1134

    Virus types . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1136

    Viruses: Structure and life cycle . . . . . . . . . . . . 1140

    Warts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1146

    Water treatment and infectious diseases . . . . . 1147

    Waterborne illness and disease . . . . . . . . . . . . . 1149

    West Nile virus . . . . . . . . . . . . . . . . . . . . . . . . . . 1153

    Whipple’s disease . . . . . . . . . . . . . . . . . . . . . . . . 1155

    Whipworm infection . . . . . . . . . . . . . . . . . . . . . 1156

    Whooping cough . . . . . . . . . . . . . . . . . . . . . . . . 1158

    Women and infectious disease . . . . . . . . . . . . . 1159

    World Health Organization (WHO) . . . . . . . . 1163

    Worm infections . . . . . . . . . . . . . . . . . . . . . . . . . 1167

    Wound infections . . . . . . . . . . . . . . . . . . . . . . . . 1171

    Yaws . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1174

    Yellow fever . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1175

    Yellow fever vaccine . . . . . . . . . . . . . . . . . . . . . . 1177

    Yersinia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1178

    Yersinia pseudotuberculosis . . . . . . . . . . . . . . . . . . 1180

    Yersiniosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1181

    Zoonotic diseases . . . . . . . . . . . . . . . . . . . . . . . . 1183

    Zygomycosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1187

    Appendixes

    Reference Tools

    Glossary............................................................ 1191

    Bibliography.................................................... 1201

    Resources......................................................... 1210

    Web Sites.......................................................... 1218

    Medical Journals.............................................. 1224

    Pharmaceutical List......................................... 1230

    Historical Resources

    Time Line of Major Developments

    in Infectious Disease................................... 1250

    Biographical Dictionary of Scientists

    in Infectious Disease................................... 1256

    Nobel Prizes for Discoveries

    in Infectious Diseases.................................. 1265

    Indexes

    Entries by Anatomy or System Affected......... 1271

    Category........................................................... 1283

    Subject.............................................................. 1295

Scroll